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Abstract 
Chronic pelvic pain is currently estimated to impact 9.2 million women in the United 
States. As many as half of these women will have comorbid conditions, such as chronic 
pain in multiple pelvic organs, mood disorder, and/or somatic functional pain disorders, 
which are often of unknown etiology and complicate already less-than-optimal treatment 
strategies.  Functional pain patients are more likely than the general population to report 
histories of early life adverse events, including abuse, neglect, and trauma.  Exposure to 
these early life stressors can have a profound lifelong impact on neurodevelopment, 
behavior, and the neuroendocrine response to stress by influencing the hypothalamic-
pituitary-adrenal (HPA) axis, the tone of which is set during this critical period of 
development.  Using an animal model of early life stress, this project evaluated changes 
in behavior and urogenital hypersensitivity in adulthood, assessed alterations in the 
regulation of the HPA axis, and investigated voluntary exercise as a potential 
therapeutic intervention. This project was the first of its kind to study the impact of early 
life stress on adult behavior relevant to pain and associated comorbidities in female 
mice.  Specifically, molecular approaches evaluated how early life stress influenced 
long-term changes in the expression of genes that regulate the HPA axis.  The impact 
of early life stress on the neuroendocrine response to acute stress in adulthood was 
evaluated by characterizing HPA axis output and the downstream immune response to 
stress in the pelvic organs.  Finally, this project provided novel preclinical model of 
exercise as an intervention for early life stress-induced urogenital pain and associated 
comorbid behaviors.  Together, this work provides insight into how early life stress alters 
the function of the nervous system, impacts the neuroimmune profile of the female 
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genitourinary tract, and whether exercise, an easily translatable intervention method, 
can attenuate the impact of early life adverse events. 
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1.1 Chronic Pelvic Pain 
In the United States alone, 9.2 million women aged 18-50 years are estimated to 
currently suffer from chronic pelvic pain (CPP), which is defined as non-cyclical pain of 
6 months duration or longer in the lower abdomen or reproductive organs.  In the 
context of this definition, 14.7% of women of reproductive age have reported CPP at 
some point in their lives (1).  Notably, more than half of these women reported the 
cause of their CPP was unknown (1).  In the United States, total annual costs for out of 
pocket expenses related to CPP are estimated to be $2.8 billion and annual indirect 
costs from lost productivity due to missing work are estimated to be $555.3 million (1).   
Functional pain disorders affecting the genitourinary system are complex, 
multifactorial syndromes of unknown etiology and are frequently associated with CPP.  
Chronic pain disorders of idiopathic origin present frustrating cases in clinical practice 
especially when diagnostic workup is disproportionate to the severity of symptoms.  
When studied by organ involvement, half of CPP syndromes are related to the 
genitourinary systems.  Urogenital laparoscopic and biopsy findings remain relatively 
unremarkable in proportion to symptom severity (2).  As a result, urogenital functional 
pain disorders are diagnosed symptomatically, in exclusion of other apparent findings, 
where pain itself is the primary symptom.  CPP is therefore a descriptive term for the 
ongoing spontaneous or evoked pain associated with such diagnoses as interstitial 
cystitis/painful bladder syndrome (IC/PBS), vulvodynia, and irritable bowel syndrome 
(IBS): syndromes that severely impact quality of life and disability.  CPP affecting the 
urogenital organs and common comorbidities are the primary focus of this dissertation 
and will be further described in the following sections. 
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1.1.1 Interstitial cystitis/Painful bladder syndrome 
Estimations indicate 11% of women and 5% of men meet the high sensitivity 
definition of IC/PBS (3-5). Direct medical costs for individual IC/PBS patients total 
approximately $4000/year (6), indicating that, at minimum, $20-40 billion dollars are 
spent each year in the United States to treat IC/PBS alone.  However, these statistics 
do not represent the full burden of this disease.  For instance, comorbidity with other 
CPP disorders is common (1, 7-10).  Up to 93% of women with IC/PBS have pelvic pain 
and more than 50% have vulvar pain (11).  Other commonly reported comorbidities 
include fibromyalgia, allergies, IBS, and mood disorder (12-16), creating a greater 
negative impact on quality of life and complicating already less-than-optimal treatment 
strategies (13, 17-22).   
Clinically, IC/PBS is defined as pelvic pain or discomfort lasting for at least 6 
weeks in duration that is perceived to be related to the urinary bladder.  Classification of 
IC/PBS must also include at least one additional urological symptom that is non-
attributable to known causes of bladder pain, such as infection or organic disease (23) 
(24, 25).  Like many idiopathic pain disorders, IC/PBS is polysyndromic, that is patients 
may exhibit one of multiple subtypes generally classified as an ulcerative or non-
ulcerative presentation (26).  Classically, a diagnosis of interstitial cystitis referred to 
observable findings on cystoscopic examinations: namely, glomerulations, overt 
histopathology, or Hunner’s ulcers (24, 25); however, the patient population was far 
more heterogeneous than the strict criteria originally defined.  Therefore, diagnoses 
today are primarily attributed symptomatically where IC/PBS subtypes may be 
differentiated by additional features, clinical presentation, or history (27).  The only FDA 
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approved treatments for IC/PBS are oral pentosan polysulfate sodium, whose 
mechanism of action is unknown, and intravesicular installation of dimethyl sulfoxide; 
off-label treatment options include oral tricyclic antidepressants or antihistamines and 
intravesicular instillation of heparin or lidocaine (28-30).   
 Reflecting the broad spectrum of clinical subtypes, the pathophysiology 
underlying IC/PBS is likely multifactorial.  A wide array of etiologies has been explored 
in IC/PBS that, when taken together, proposes a cyclical cascade of events involving 
neurogenic inflammation, a hyper-responsive immune system, and urothelial lining 
dysfunction that collectively results in chronic pain.  The initial insult that triggers IC/PBS 
pathophysiology is less clear.  As IC/PBS is primarily an adult-onset disorder, 
identification of the prodrome will need to be a priority in order to halt the circular nature 
of the early-pathophysiology.  To that end, a number of urine biomarkers associated 
with IC/PBS, such as interleukin-6 (IL-6) (31-34), histamine (31), and nerve growth 
factor (NGF) (35, 36), have been identified.   
1.1.2. Vulvodynia  
The International Society for the Study of Vulvovaginal Disease (ISSVD) defines 
vulvodynia as “vulvar discomfort, most often described as a burning pain without 
relevant visible findings or a specific, clinically identifiable, neurologic disorder” (37).  
Patients with vulvodynia may present with a variety of symptom characteristics.  The 
pain associated with localized and generalized vulvodynia is further distinguished 
between provoked or unprovoked pain, or a mix of both while symptom onset of these 
subtypes may arise suddenly or gradually (38).  Despite the variability in clinical 
presentation, allodynia of the vulva, vestibule, or vaginal canal are hallmark symptoms 
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of vulvodynia and together are qualitatively described as a burning, stinging, or itching 
sensation (39, 40).  Diagnosis is primarily made by cotton-swab examination of the 
vulva as a means to reproduce severe pain or discomfort (38).  As such, in the absence 
of other clinically identifiable organic disease, vulvodynia is a diagnosis of exclusion.  
Observed erythema is minor and biopsy of the vulva is pathologically unremarkable; 
therefore, the diagnosis of vulvodynia more accurately reflects symptomatology as an 
idiopathic pain disorder rather than a disease process.  Vulvodynia has been shown to 
be significantly associated with a diminished quality of life and increased rates of co-
morbid diagnoses of fibromyalgia, IBS, and depression (17).  
At any given time, vulvodynia affects 4% of women in the United States.  Lifetime 
cumulative evidence predicts 16% of women among the general population will have 
vulvodynia at some point in their lives (41, 42).  Conservative estimates suggest the 
national costs associated with vulvodynia range $31-72 billion annually (43).  Similar to 
idiopathic pain disorders in general, vulvodynia is proposed to be of multifactorial 
nature.  Given the elusive etiology, managing symptoms associated with vulvodynia is 
the primary focus in the literature.  The magnitude of treatment options span non-
specific lifestyle interventions, topical or oral medications, injections, physical therapy, 
and surgical procedures (44).   Recently, epidemiological studies have found 
predispositions between the onset of vulvodynia as triggered by a traumatic life event or 
a history of early life stress (45).  Antidepressant (46-48) and anticonvulsant (49, 50) 
medication have been shown to alleviate symptoms associated with vulvodynia, and, as 
a first-line treatment, suggests a psychosomatic pathophysiologic component to the 
disease process; however, other molecular mechanisms are at play.   
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1.1.3. Comorbidities 
Up to 50% of women diagnosed with CPP experience symptoms from more than 
one disorder (22).  While clinical features such as dysfunctions in the immune system, 
central nervous system, and peripheral nervous system are common characteristics 
across CPP syndromes (1, 7), the underlying etiology bridging these syndromes 
remains to be elucidated.  While CPP frequently affects more than one pelvic organ, 
formal diagnosis of a secondary disorder is not necessarily reflective of actual symptom 
patterns.  For instance, 88% of sexually active women with CPP and no formal 
gynecological diagnosis reported that symptom exacerbation due to sexual intercourse 
was the greatest interference to their quality of life and the chief cause of their health 
distress (1).  Accordingly, vaginal pain is also reported in 52% of women diagnosed with 
IC/PBS (51).  Unfortunately, neither the underlying etiology of CPP syndromes nor and 
the associated comorbidities involving the genitourinary systems has yet to be 
discerned.   
Patients with chronic pain involving pelvic or genital dysfunction are less likely to 
seek treatment and, for those that do, the combined apparent lack of organ pathology 
with comorbid mood disorder prompts clinicians to approach these patients as exhibiting 
a psychological, rather than a physiological, disturbance.  As evidence of this diagnostic 
pattern, women with functional pelvic pain disorders are more likely to be given a 
primary diagnosis of anxiety or depression; however, treatment with antidepressants, 
the most common pharmacological intervention for this group, does not necessarily 
relieve their pain (52).  Vulvodynia, in particular, has been associated with other chronic 
pain disorders of the pelvic organs including IC/PBS and increased rates of mood 
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disorders such as depression or anxiety (53).  Conversely, odds of vulvodynia are more 
likely among women with antecedent mood disorders (54) suggesting higher levels of 
chronic stress among these patients serves to increase symptom severity (55).  Indeed, 
vulvodynia patients demonstrate a blunted serum cortisol cycle that manifests in a 
variety of emotional and physiological indicators (56). 
In addition to presenting with symptomology in adjacent organs, CPP patients 
are also more likely to present with somatic functional pain disorders affecting more 
discreet locations such as migraine, fibromyalgia, or temporomandibular joint disease. 
This disparate localization of affected regions, combined with comorbid mood disorder, 
has led scientists and clinicians to investigate central sensitization or altered pain 
processing as potential etiologies.   
1.2 Hypothalamic-pituitary-adrenal gland axis  
One area of research that has come under recent increasing investigation 
involves the links between stress and pain physiology.  The influence of stress on the 
modulation of disease has been studied for many years.  In particular, chronic exposure 
to stress can raise blood pressure, increase the risk of heart attack and stroke, slow 
wound healing, increase vulnerability to anxiety, and depress the immune response 
(57).  Differential effects can occur depending on the nature of the stressor, i.e. 
physiological or psychological, and in what stage of life the stress is experienced.  It is 
during the earliest stages of life that chronic stress exerts profound life-long molecular, 
cellular, and neurophysiological changes.  By impacting neurodevelopment and the 
response to acute stress in adulthood, early life stress can diminish health, increase 
susceptibility to disease, and impact premature mortality (58).  Unfortunately, social 
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trends regarding childhood maltreatment, poverty, and witnessing substance abuse in 
the home are increasing in the United States (59).  In fact, the national rate of 
maltreatment in 2011, reported primarily from professional sources such as primary 
care physicians and investigated by Child Protective Services, was 27.4 per 1,000 
children in the national population, a trend which had steadily increased over the 
previous 5 years (60).  In 2011, this resulted in the confirmation of 676,569 unique 
cases of child abuse and neglect in the United States alone, and 27.1% of victims were 
less than two years of age (60).   
In particular, stress experienced during critical periods of development exert 
lifelong impacts on the health of that individual by altering the programming of the 
body’s physiological stress response system: the hypothalamic-pituitary-adrenal gland 
(HPA) axis.  The HPA axis is responsible for initiating and coordinating the physiological 
response to acute or prolonged stress (61). Ultimately, this results in a systemic 
response designed to facilitate the physiological need to endure, fight, or flee from a 
perceived threat and eventually return to homeostasis (62).  Systemic effects of HPA 
axis activation include shifting energy balance from anaerobic to aerobic metabolism, 
increasing water reabsorption in the kidney, and systemic immunosuppression (63).  
Due to its potency, altered programming of HPA axis regulation impacts central nervous 
system architecture and the peripheral neuroendocrine response to stress (64).   
Under stressful conditions, parvocellular cells within the paraventricular nucleus 
(PVN) of the hypothalamus are activated via noradrenergic, adrenergic, and peptidergic 
innervation from brainstem nuclei to release corticotropin-releasing factor (CRF) into the 
median eminence.  CRF is then transported through the hypophyseal portal system to 
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stimulate the release of adrenocorticotrophic hormone (ACTH) from corticotrophs in the 
anterior pituitary.  ACTH is released into systemic circulation and stimulates the release 
of glucocorticoids, cortisol in humans and corticosterone in rodents, and 
mineralocorticoid from cells in the zona fasciculata and zona glomerulosa of the adrenal 
cortex, respectively (65-67).  Basal levels of glucocorticoid release follow diurnal 
rhythms, with serum concentrations peaking at the beginning of the active period (68).  
Glucocorticoids bind one of two nuclear receptors.  The first is the high-affinity 
mineralocorticoid receptor (MR) responsible for maintaining the diurnal tone of the HPA 
axis (69).  The second is the low-affinity glucocorticoid receptor (GR), which is bound 
during surges in glucocorticoids (69).  Both MR and GR are highly expressed in 
hippocampal neurons that send glutamatergic input to GABAergic PVN relays within the 
hypothalamus, activation of which shuts down the HPA axis at the cessation of a 
psychogenic stress response (70-72).  This process of HPA axis negative feedback 
from limbic circuitry is programmed during postnatal development during the stress 
hyporesponsive period (73-77), which, in rodents, is driven by maternally-maintained 
buffering of neonatal HPA axis activation through physical presence of the dam (78).  
Activity of MR and GR are relatively slow-acting and effect long-term changes in gene 
transcription (79).  Fast-acting, nongenomic effects of glucocorticoids have also been 
observed at the membrane (80, 81).  While the receptor involved has not been 
identified, intracellular signaling cascades resulting in endocannabinoid synthesis have 
been observed upon glucocorticoid binding.  These endogenous cannabinoid ligands 
modulate synaptic plasticity through retrograde action on presynaptic neurotransmitter 
release.  In the case of parvocellular corticotrophs of the hypothalamus, 
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endocannabinoid activity reduces presynaptic glutamate release and thereby facilitates 
rapid negative feedback (80).  In the hippocampal neurons, fast-acting effects of 
glucocorticoids stimulate a putative Gi/o signaling cascade that ultimately results in the 
recruitment and retention of N-Methyl-D-aspartic acid (NMDA)-receptors at the cell 
surface (82). 
HPA axis modulation is also coordinated by two G-protein coupled receptors 
(CRF1 and CRF2) that bind CRF and three related endogenous ligands: urocortin (Ucn) 
1-3.  CRF preferentially binds CRF1, Ucn1 binds CRF1 and CRF2 with equal affinity, and 
Ucn2 and Ucn3 preferentially bind CRF2 (83-85).  CRF1 and CRF2 generally evoke 
opposing effects, causing activation and suppression of the HPA axis, respectively. This 
has been evidenced in rodent studies where activation of CRF1 increases anxiety-like 
behaviors in rodents and pharmacological antagonism or genetic deletion of CRF1 has 
been shown to be anxiolytic, whereas pharmacological blockade or genetic deletion of 
CRF2 is anxiogenic (86-88).   
Limbic structures work in conjunction with one another to maintain homeostatic 
regulation of the HPA axis.  The PVN is heavily innervated by GABAergic interneurons 
that themselves are responsive to limbic activity (89).  Under normal circumstances, 
limbic structures such as the amygdala and hippocampus activate and inhibit the HPA 
axis, respectively, through modulation of the local inhibitory tone (65, 90).  The central 
nucleus of the amygdala (CeA) is well recognized as a key integrator of stress-related 
behaviors such as fear responses (91).  Under conditions of chronic stress, however, 
production of CRF is increased in the CeA, consequently enhancing CRF production in 
the PVN and glucocorticoid release (92). In the hippocampus, chronic stress can result  
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Figure 1.1 Schematic diagram of downstream activation and limbic control of the 
hypothalamic-pituitary-adrenal (HPA) axis. Acute stress induces activation of the 
parvocellular neurons of the paraventricular neurons (PVN) of the hypothalamus and 
synthesis and release of corticotropin-releasing factor (CRF) and arginine vasopressin 
(AVP) into the hypophysial portal system.  Both CRF and AVP will reach the anterior 
pituitary and synergistically promote the release of adrenocorticotrophic hormone 
(ACTH), which will act at the adrenal cortex to produce glucocorticoids (cortisol in 
humans; corticosterone in rodents).  Glucocorticoids act in a negative feedback loop at 
the hypothalamus and anterior pituitary to cease production of CRF and ACTH, 
respectively, as well as at higher limbic structures, including the amygdala and 
hippocampus, which respectively activate and inhibit the hypothalamus.  Peripheral 
release of CRF also acts on mast cells and enteric neurons. 
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Figure 1.2 
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Figure 1.2 Schematic diagram of the binding scheme and cross-talk between 
corticotrophin-releasing factor (CRF) and glucocorticoid receptors. CRF and the related 
Urocortins (Ucn) 1–3 act via a two-receptor system to regulate the hypothalamic-
pituitary-adrenal gland axis.  Activation of CRF receptor 1 (CRF1) occurs via CRF or 
Ucn1 and activation of CRF2 occurs via all three Ucns.  Activation of CRF1 has been 
shown to increase anxiety-like behaviors in rodents as well as increase colonic motility 
and hypersensitivity.  In contrast, activation of CRF2 has largely been shown to be 
anxiolytic and can increase urinary bladder hyperactivity and hypersensitivity.  
Activation of CRF2 has also been shown to inhibit CRF1 and activation of either 
glucocorticoid receptor (GR) or mineralocorticoid receptor (MR) can inhibit CRF 
production and signaling. 
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in decreased expression of GR or increased resistance to GR binding (93), thereby 
diminishing inhibitory activity onto the HPA axis and subsequently enhancing 
glucocorticoid release.     
1.3 Mast cells 
In addition to CRF systems, one commonality linking chronic stress to multiple 
categories of peripheral pathology is the infiltration and activation of mast cells.  Part of 
the innate immune response, mast cells are primarily resident in tissues interfacing with 
the environment: the integument, meninges, and respiratory-, gastrointestinal-, and 
genitourinary tracts (94-96).  Hematopoietic progenitors of mast cells develop in the 
bone marrow, are lightly or non-granulated, and express the stem cell factor (SCF) 
receptor c-kit and the IgE receptor FcɛRI (97).  A complex network of signaling and 
transcription factors regulates the recruitment of immature mast cells to the peripheral 
tissue where they will take up residence and undergo maturation.  Once mature, mast 
cells are generally considered to be terminally differentiated and do not undergo cell 
division (98), therefore increases in mast cell infiltration in the periphery, associated with 
inflammation or disease, is attributed to active recruitment and maturation of 
continuously released mast cell progenitors from the bone marrow (99, 100). Two 
subtypes of mast cell populations have been described in mouse (101) and human 
(102): mucosal mast cells and connective tissue mast cells.  While each subtype 
responds to different compounds, and differs in size and granular content, both exhibit 
similar histochemical properties, express the SCF receptor, and are derived from the 
same population of embryonic stem cell progenitors (103).  Levels of mast cells may 
also increase in non-barrier tissues such as kidney upon injury or inflammation (104). 
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Ample evidence exists for the role of mast cells in driving neurogenic 
inflammation and visceral afferent sensitization in mucosal diseases such as IBS and 
asthma (105, 106).  In addition, mast cell stabilizing agents such as sodium 
chromoglycates are used to treat such diseases.  Mechanistically, mast cell stabilizers 
are thought to inhibit IgE-directed mediator release from human mast cells (107), but 
their specific mode of action remains unclear.  Due to their safety profile, they are widely 
prescribed as treatment for asthma, rhinitis, and other wheezing disorders as an 
alternative to corticosteroids (108, 109).  Mast cell stabilizers also have therapeutic 
efficacy in conditions that feature non-allergen directed mast cell activation, such as 
exercise-induced bronchoconstriction (110-114). Furthermore, in animal models of CPP, 
mast cell stabilizers have been shown to prevent, but not reverse, stress and 
inflammation-induced colorectal hypersensitivity (115-117).   
Mast cells express both functional CRF receptors and CRF mRNA and, 
accordingly, can respond to and release CRF and Ucn1, as well as increase receptor 
expression following stimulation with lipopolysaccharide (LPS) administration (118, 
119).  Mast cell-dependent vascular permeability in the skin is mediated by CRF1, and is 
prevented by antalarmin, a specific CRF1 antagonist (120).  As such, mast cells have 
dual functions: as a sensory cell, it responds to environmental cues, and, as an effector 
cell, it releases biologically-active mediators such as cytokines, tryptase, proteases, and 
CRF itself (119, 121-123).  Mast cell paracrine functions involve degranulated tryptase 
and histamine binding to protease activated receptors (PAR) and histamine receptors, 
respectively, on nearby visceral afferents, which can drive stress-mediated 
sensitization, a process shown to contribute to chronic functional pain (124, 125).  This 
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nerve-mast cell axis and ensuing neuropeptide release from peripheral termini (126) is 
perpetuated by the chemoattraction of mast cells to antidromic release of 
neuropeptides, such as substance P and calcitonin gene-related peptide (CGRP) (127, 
128).  In turn, CGRP has been shown to increase expression of tumor necrosis factor 
(TNF)-α by mast cells (129).   
 Given the molecular evidence and the close anatomical approximation between 
mast cells and peripheral nerves (130), bidirectional neuroimmune signaling likely 
contributes to propagation of painful stimuli.  As such, the critical role of mast cells in the 
development and maintenance of CPP continues to be investigated in both clinical and 
preclinical settings. Sensory innervation of the viscera is primarily provided by 
unmyelinated (C-fiber) or thinly myelinated (Aδ-fiber) peptidergic neurons (131-133). A 
number of receptors expressed by these afferents, including transient receptor potential 
vanilloid 1 (TRPV1) (134-136), transient receptor potential ankyrin 1 (TRPA1) (137, 
138), and PAR2 (139-141), transmit noxious stimuli and are necessary for the 
development of inflammatory-induced hyperalgesia. Tryptase, a major component of 
mast cell granules, can bind to and activate PAR2, which has been shown to sensitize 
TRPV1 and TRPA1 in vivo (139, 142).  Interestingly, stress ligands such as CRF and 
Ucn are expressed in the bladder (143) and mediate neuroimmune dysfunction in 
animal models of cystitis (144, 145).  Visceral signaling of the physiological stress 
response results in phenomena of heightened neuro-immune interactions and visceral 
hypersensitivity in animal models of IBS (146-149), vulvodynia (150), and IC/PBS (144, 
151-153).  
1.4 Inflammation 
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 Numerous inflammatory mechanisms contribute to the spectrum of CPP and 
comorbid mood disorders.  The extent of rote inflammatory infiltrate observed in CPP 
syndromes is generally below histological levels of detection as no overt 
pathophysiological observations are made upon pelvic organ biopsy samples from CPP 
patients (2).  Yet proinflammatory molecules such as the cytokines interleukin-6 (IL6) 
and TNF-α, among other biomarkers, are elevated in urine or serum of CPP patients 
(31-36, 154, 155).  The role of cytokines as contributors to hyperalgesia and allodynia is 
well delineated in injury and inflammatory models (156, 157). The normally low levels of 
cytokines secreted by human smooth muscle cells, such as the detrusor in the urinary 
bladder, are enhanced by exposure to inflammatory mediators (158).  Other mediators 
of inflammation include neurotrophins, protons, prostaglandins, and bradykinin and are 
likewise implicated in the direct sensitization of nociceptive afferents leading to 
persistent pain (159).   
 Numerous studies support the pro-nociceptive effect of NGF (160), which was 
first described following efforts undertaken by Rita Levi-Montalcini (161).  The biological 
action of NGF is mediated through the high-affinity tyrosine receptor kinase A (TrkA) 
and low-affinity pan-neurotrophin receptor 75 (p75).  Local injection of NGF induces 
hyperalgesia or allodynia that lasts up to 49 days (162-164).  NGF also exerts 
proinflammatory effects by acting on cells of the immune system (165, 166), particularly 
mast cells (167-169).  Selective overexpression of NGF in the bladder can result in 
hyperreflexia, hyperinnervation, and increased mast cell infiltrates (170). 
Hyperexcitability of bladder afferents has also been reported following intrathecal 
administration of NGF (171).  In multiple studies, cyclophosphamide-induced bladder 
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inflammation has been shown to increase activity in signaling pathways known to be 
downstream of TrkA, including phosphorylation of Erk1/2 in bladder afferents (172, 
173).  Erk1/2 are serine/threonine kinases phosphorylated downstream of the Ras-Raf-
MEK signaling cascade required for subsequent enzyme activation (174).  Several 
studies have shown a potential analgesic effect of Erk1/2 antagonists.  For instance, the 
severity of inflammation and hyperalgesia induced by experimental cystitis was 
attenuated with an agonist of the cannabinoid receptor 2 (CB2) that was Erk1/2-activity 
mediated (175, 176).  Furthermore, behavioral indicators associated with experimental 
cystitis could be attenuated with systemically-administered NGF neutralizing antiserum 
or intravesicular infusion of a nonspecific Trk receptor antagonist (177) and highlights a 
dominant role for this neurotrophin with direct relevance to IC/PBS patients (178).   
 Biopsy samples from vulvodynia patients have found increases in the pro-
inflammatory cytokines IL-1 and TNF-α (179, 180), both of which have been shown to 
be produced by activated mast cells (181).  Increased activity of IL-1β is associated with 
diminished activity of the associated IL-1 receptor antagonist (IL-1RA), which is 
otherwise decreased in vulvodynia patients (182), and polymorphisms in allele 2 of the 
IL-1RA gene are more prevalent in patients with chronic vulvar pain (179, 183, 184).  
Moreover, inflammatory challenge results in a blunted IL-1RA response in vulvodynia 
patients in vivo (182) and increased IL-1β among tissues derived from vulvodynia 
patients (185). There also exists strong evidence to link cytokine-induced activation of 
the HPA axis, particularly IL-1β [For review: (186)].  Stress-induced elevations in IL-1β 
increases HPA axis activity that is blocked with pre-treatment of IL-1RA (187).  This 
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suggests that peripheral cytokines can influence central perceptions of pain routed 
through limbic and suprahypothalamic brain regions.   
 Another important immunoregulatory cytokine is IL10, typically considered to be 
a molecule with anti-inflammatory properties and serves to limit tissue damage and 
restore homeostasis (188, 189).  Proinflammatory stimuli stimulate the secretion of IL10 
from a variety of cell types of the innate and adaptive immune systems.  For instance, 
secretion of IL10 from macrophages leads to downregulation of its own expression in an 
autocrine fashion (190).  IL10 deficient mice develop inflammatory bowel disease that 
surprisingly is exacerbated in mast-cell deficient double knock-out mice (191).   
Conversely, excess IL10 can be detrimental to the system by hindering the host 
response to pathogenic presence and preventing resolution of tissue damage.   
1.5 Exercise 
 The lack of feasible treatment options for chronic pain patients has led 
investigators to evaluate the efficacy of alternative treatment strategies.  Human studies 
reveal that regular exercise leads to improvements in symptom severity among 
fibromyalgia patients and those with other types of chronic muscle pain (192).  For 
instance, land or water based aerobic exercise and strength-based exercises improved 
aerobic physical fitness, physical function, and depression among fibromyalgia patients 
(193, 194).  Exercise has also been shown to improve symptom scores of depression 
and anxiety (195-197).  Although CPP does not involve overt musculoskeletal 
dysfunction, patients with IBS also benefit from exercise in randomized controlled trials 
(198-203).  Although women with dysmenorrhea and premenstrual symptoms benefit 
from exercise (204, 205), the favorable effects of exercise for women with non-cyclical 
21 
 
urogenital pain have not been tested.  For instance, survey analysis of IC/PBS patients 
revealed exercise as a helpful therapy among other complementary and alternative 
therapies, but randomized controlled trials have not been conducted to definitively 
support this finding (206).   
 Exercise has been shown to induce numerous beneficial changes in the 
neuroendocrine-immune system axis by altering the systemic cytokine profile in the 
periphery. For instance, it was discovered in the last ten years that skeletal muscle is 
itself a large endocrine organ.  Skeletal muscle-derived cytokines are secreted during 
muscle contraction and these “myokines” have autocrine, paracrine, and endocrine 
effects (207).  The first myokine discovered was IL6, which increases in plasma 
concentration with increasing duration and intensity of exercise that is not associated 
with muscle damage (154, 207-209).  Serum concentrations of IL6 may increase 100-
fold during sustained exercise, and levels decline sharply following the cessation of 
exercise.  A surge in a classically pro-inflammatory cytokine is a somewhat conflicting 
idea, because IL6 is typically associated with chronic inflammation and immune 
activation with detrimental health effects (210).  However, a transient increase in IL6 
during exercise without a subsequent surge in TNF-α appears to have anti-
inflammatory, rather than pro-inflammatory, effects.  Peripheral administration of 
cytokines will also impact the central nervous system (211).  Mechanisms by which 
peripheral cytokines influence synaptic development, neurogenesis, and brain circuitry 
are of enormous interest because administration of cytokines in dosages and time-
courses that mimic acute activation of the innate immune system induces protective 
behavioral repertoires responsible for sustaining the organism during threats (212-215).  
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However, administration of cytokines that mimics chronic exposure is associated with 
chronic inflammation, neuropsychiatric symptoms, and neurogenic inflammation (216-
218) and LPS-induced increase in circulating cytokines has been shown to directly 
activate the HPA axis and induce anhedonic-behaviors (219).   
One way in which cytokines influence brain function is by interfering with the 
phosphorylation of tyrosine receptor kinase B (TrkB), the receptor for brain-derived 
neurotrophic factor (BDNF) (220).  The TrkB signal is transduced via intracellular 
signaling cascades including stimulation of PI3K-Akt, PLCγ, and Erk pathways (221).  
These pathways control many aspects of cell physiology, including the promotion of 
growth and survival, plasticity, and differentiation.  Expression of BDNF in the 
hippocampus is upregulated by neuronal activity secondary to exercise or cognitive 
challenges (222, 223).  The mechanism by which hippocampal BDNF potentiates 
glutamatergic input to inhibitory interneurons in the hypothalamus is dependent on both 
TrkB and N-methyl-d-Aspartate receptors (NMDAR) signaling (224) and therein 
regulates negative feedback upon the HPA axis.    
 There is additional triangular cross-talk between skeletal muscle (acting as an 
endocrine organ), the hypothalamus, and the immune system (208).  Exercise 
increases mRNA expression of neurotrophic factors important in synaptic plasticity, 
neurogenesis, and neuronal structure in the central nervous system (225).  
Systemically, exercise induces the secretion of myokines that exert broad effects on 
chronic low-levels of inflammation such as those observed in CPP syndromes (208, 
226).  Overall, while many mechanisms may be involved, extensive evidence suggests 
that exercise improves cytokine profiles reflective of chronic, low-level inflammation and 
23 
 
influences brain neurogenesis, plasticity, and behavior, mechanisms implicated as 
contributing to depression and CPP in human patients.   
1.6 Neonatal Maternal Separation 
Subsets of CPP patients are more likely to report histories of early life adverse 
events that in turn increase the risk of developing a CPP syndrome later in life (227, 
228).  The rodent model of neonatal maternal separation (NMS) provides an opportunity 
to study the effects of early life adverse events upon the structure and function of the 
nervous system by modeling chronic stress during the critical period of postnatal 
neurodevelopment.  In fact, chronic stress experienced during early neurodevelopment 
has been proposed to contribute to functional pain disorders (57), yet the relationships 
between female urogenital pain and other comorbid somatic and behavioral conditions 
have largely gone unstudied in rodent models.  Animal models of NMS have 
demonstrated increased colorectal hypersensitivity, aberrant responses to future stress, 
and increased susceptibility to infection or experimental colitis in adulthood (146, 229, 
230).  While this model of early life stress is well established in rats, it has not been 
used to study the effect on urogenital hypersensitivity in either rats or mice.  
Physiological and behavioral changes persisting to adulthood result from NMS during 
the first few weeks of life.  This section will briefly describe the different NMS paradigms 
and the resultant molecular and behavioral changes in adulthood. 
In the 1950’s, Seymour Levine catalyzed the study of the field in which neonatal 
stimulation impacted the developing organism (231).  Neonatal rat pups were subjected 
to stimuli such as 3-minutes of isolation, stroking, starvation, and shock, which resulted 
in altered responses to stressful stimuli later in life (232-237).  It was during these early 
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studies that he proposed the idea of critical periods of development: when neonatal 
manipulation occurs during a specific window of postnatal development it manifests 
long-lasting effects (238).  Over the following decades, differing experimental 
manipulations, nature of the insults, and duration of the condition across the critical 
window resulted in differential outcomes.  From this body of knowledge emerged 
insights into the mechanisms behind resilience and vulnerability.  Discrepancies 
between animals, strain, and sex have also been investigated. 
Rodent NMS involves the physical separation of the pups from the presence of 
the dam on a scale from minutes to hours to days.  Typically, the less severe models of 
deprivation (daily 15 minute separations) result in behaviors of resiliency: reduced 
anxiety-like behaviors, reduced CORT, and enhanced negative feedback onto the HPA 
axis (239, 240).  Exposure to prolonged periods of separation, on the other hand, 
generally increases output of the HPA axis resulting in enhanced duration of ACTH and 
CORT release following a stressful event (64, 241-243) and vulnerability to anxiety-like 
behaviors, fearfulness, and susceptibility to ethanol preference (244-246). Significant 
effects of strain were observed in prepulse inhibition and startle-reflex (247) but not 
anxiety-like behaviors (248).  One study by Millstein et al. (248) found the effect of 
mouse strain only impacted the behavior of the dam during NMS but not anxiety-like 
and depression-like behaviors exhibited by the pups in adulthood.  While no studies 
have evaluated the effect of strain differences on visceral hyperalgesia following early 
life stress, the C57Bl/6 strain has already been shown to be an acceptable strain with 
which to evaluate stressful manipulation during the postnatal window (149, 230, 243, 
249) and is the strain utilized in the present study. 
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  Interestingly, there appears to be a propensity for sex discrepancies for 
behavioral alterations in models of rodent stress (250-255).  Anhedonia, increased 
immobility during forced swim test, and decreased exploration of the open arms in the 
elevated plus maze, all behaviors thought to be reflective of depression or anxiety, were 
observed in male Sprague-Dawley rats following NMS (256).  Romeo et al., (243) 
reported sex differences in adult mice following NMS where males exhibited increased 
and females exhibited decreased anxiety-like behavior.  In contrast, Aisa et al., (241) 
reported increased immobility during the forced swim test in female rats following NMS 
but no change in anxiety-like behaviors.  Taken together, the prevalence of chronic pain 
and affective disorders in women and the evidence of a sex-divergent manifestation of 
early life adverse events, indicates a need to evaluate adult behaviors in the NMS 
model.  
1.7 Study Significance 
 The goal of this study is to evaluate pain modulatory mechanisms involved in 
female urogenital hypersensitivity resulting from early life stress.  The central hypothesis 
of this proposal is that NMS reduces negative feedback onto the HPA axis and drives 
urogenital hypersensitivity and depressive behaviors in female mice, which can be 
attenuated by exercise.  The following series of experiments determined the underlying 
mechanisms mediating these changes in behavior.  Together, these investigations 
define the neuroendocrine changes responsible for urogenital hypersensitivity and 
altered behavior consequential to early life stress. 
 The first study in this dissertation tested the hypothesis that NMS produces long-
lasting vaginal hypersensitivity, somatic allodynia, and anxiety-like behaviors in female 
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mice.  Neonatal stress or injury in rodents produces a phenotype in adulthood similar to 
what is seen in IBS patients, such as visceral hyperalgesia, increased firing rates of 
dorsal horn neurons responding to colonic distension, and increased expression of TRP 
channel subtypes in sensory neurons that innervate the colon (146-149).  Furthermore, 
patients diagnosed with IBS often present with secondary pain disorders affecting the 
pelvic viscera such as IC/PBS and vulvodynia or diffuse somatic pain syndromes such 
as fibromyalgia (257, 258).  Experiments in this study evaluated the effect of NMS on 
the sensitivity of the vagina and hindpaw, open-field exploratory behavior, and 
expression of genes involved in negative feedback onto the HPA axis. 
 The second study in this dissertation determined the effect of neonatal and adult 
stress on bladder hypersensitivity and dysfunction, limbic regulation of the HPA axis, 
and downstream neurogenic inflammation of the bladder.  Urogenital pain patients 
commonly report stress-related symptom onset or exacerbation of dormant symptoms, 
as well as difficulty coping with stressful situations and comorbid depression and/or 
anxiety (7, 15, 17, 259-263). Patients who suffered early life adverse events commonly 
display altered functional output of the HPA axis (76, 264-266), which is largely 
regulated by feedback from higher limbic structures via CRF and glucocorticoid 
receptors (65, 90).  Experiments in this study evaluated the impact of NMS and water 
avoidance stress (WAS) on bladder and colorectal sensitivity and dysfunction, mast cell 
activity and evidence of neurogenic inflammation in the pelvic organs, and HPA axis 
output and regulation. 
 The final study in this dissertation evaluated the potential of exercise as an 
intervention for the visceral hypersensitivity and associated behaviors in NMS mice.  
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Exercise has been shown to confer protective benefits for neurological disorders such 
as Parkinson’s disease, Alzheimer’s disease, stroke, and traumatic brain injury (267-
269).  Clinically, exercise reduces the effects of depression and anxiety and associated 
perceptions of pain (199, 270, 271).  Voluntary exercise in the post-weaning period has 
been shown to attenuate neuromolecular and behavioral changes associated with a 
dysfunctional HPA axis implicated in NMS-induced visceral hypersensitivity (272).  This 
study evaluated visceral hypersensitivity, anhedonia behaviors, mast cell degranulation 
in the bladder, and hippocampal regulation of the HPA axis in sedentary and exercised 
NMS mice. 
 Women with idiopathic, chronic pelvic pain affecting the urogenital organs have a 
diminished quality of life, loss of productivity, and poor health outcomes.  This project is 
therefore significant because it provides the first rodent model to demonstrate the 
impact of early life stress on female urogenital physiology, pain, and dysfunction, as well 
as novel preclinical evidence of voluntary exercise as a potent interventional method.  
Enhancing our understanding of these frustrating and debilitating conditions provides a 
framework by which to fully appreciate the lifelong impact of early life adverse events, 
evaluate future therapeutic options, and potentially treat a population of patients 
suffering from chronic pain.   
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Chapter 2 
 
Vaginal hypersensitivity and hypothalamic-pituitary-adrenal axis dysfunction as a 
result of neonatal maternal separation in female mice 
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2.1 Abstract 
Early life stress can permanently alter functioning of the hypothalamic-pituitary-
adrenal (HPA) axis, which regulates the stress response and influences the perception 
of pain. Chronic pelvic pain patients commonly report having experienced childhood 
neglect or abuse, which increases the likelihood of presenting with comorbid chronic 
pain and/or mood disorders. Animal models of neonatal stress commonly display 
enhanced anxiety-like behaviors, colorectal hypersensitivity, and disruption of proper 
neuro-immune interactions in adulthood. Here, we tested the hypothesis that early life 
stress impacts vaginal sensitivity by exposing mice to neonatal maternal separation 
(NMS) for 3hr/day during the first two (NMS14) or three (NMS21) postnatal weeks. As 
adults, female mice underwent vaginal balloon distension (VBD), which was also 
considered an acute stress. Before or after VBD, mice were assessed for anxiety-like 
behavior, hindpaw sensitivity, and changes in gene and protein expression related to 
HPA axis function and regulation. NMS21 mice displayed significantly increased vaginal 
sensitivity compared to naïve mice, as well as significantly reduced anxiety-like behavior 
at baseline, which was heightened following VBD. NMS21 mice exhibited significant 
thermal and mechanical hindpaw hypersensitivity at baseline and following VBD. 
NMS14 mice displayed no change in anxiety-like behavior and only exhibited 
significantly increased hindpaw mechanical and thermal sensitivity following VBD. 
Centrally, a significant decrease in negative regulation of the HPA axis was observed in 
the hypothalamus and hippocampus of NMS21 mice. Peripherally, NMS and VBD 
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affected the expression of inflammatory mediators in the vagina and bladder. 
Corticotropin releasing factor (CRF) receptor and transient receptor potential (TRP) 
channel protein expression was also significantly, and differentially, affected in vagina, 
bladder, and colon by both NMS and VBD. Together these data indicate that NMS 
affects both central and peripheral aspects of the HPA axis, which may drive changes in 
vaginal sensitivity and the development of comorbid chronic pain and mood disorders. 
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2.2 Introduction 
Growth and development during the formative years, beginning prenatally and 
lasting until age 5, occurs at a pace exceeding that of any subsequent stage of life 
(273).  As a result, the nervous system is remarkably pliant to nurturing and adverse 
events during this period of development (274).  Psychological stressors, such as 
childhood neglect or abuse; low socioeconomic status; and witnessing domestic 
violence, parental discord, or crime in the home, have profound lifelong impacts on 
behavior and also serve as risk factors for functional pain disorders later in life (275-
278).  Accordingly, a significant subset of patients with functional pelvic pain disorders, 
including irritable bowel syndrome (IBS), interstitial cystitis/painful bladder syndrome 
(IC/PBS), and vulvodynia, report a history of adverse childhood events such as abuse 
or neglect (279-281).  Subsets of these patients report stress-related symptom onset or 
increased severity, have difficulty coping with stressful situations, and suffer from 
depression and/or anxiety (7, 17, 282).  
The comorbidity between mood disorders and chronic pelvic pain is due, in part, 
to altered functioning of corticotropin-releasing factor (CRF)-responsive regions of the 
brain, including the hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress 
response and influences the perception of pain (227, 283, 284). Under stressful 
conditions, CRF is secreted from the paraventricular nucleus (PVN) of the 
hypothalamus and induces the systemic release of adrenocorticotropic hormone 
32 
 
(ACTH) from the anterior pituitary corticotrophs. ACTH then stimulates glucocorticoid 
(cortisol in humans and corticosterone in rodents), synthesis and secretion from the 
adrenal cortex (65, 90). Activity of the HPA axis is largely regulated by positive and 
negative feedback within the hypothalamus and from higher limbic structures, including 
the amygdala and hippocampus, which stimulate and inhibit CRF release, respectively 
(65, 90). Glucocorticoid-driven negative feedback occurs through two receptors, 
glucocorticoid receptor (GR) and mineralocorticoid receptor (MR), which are relatively 
slow-acting and effect long-term changes in gene transcription (79). The two CRF 
receptors, CRF1 and CRF2, bind CRF and the related Urocortins (Ucn1-3) with varying 
affinity and work in opposition to one another to facilitate and depress activation of the 
HPA axis, respectively (285).  
Neonatal maternal separation (NMS) in rodents has been used for several 
decades as a model of early life stress that significantly affects functioning of the HPA 
axis. NMS has generally been shown to increase the output of the HPA axis, evidenced 
as enhanced anxiety-like behaviors and prolonged release of ACTH and corticosterone 
following a stressful event (64, 241-243). CRF production in both the PVN and the 
central nucleus of the amygdala (CeA) (241, 242, 286), as well as altered hypothalamic 
and limbic CRF receptor and GR expression (64, 241, 242, 287), have been reported in 
NMS rats. Peripheral CRF release, in response to chronic stress, has been shown to 
promote neurogenic inflammation through mast cell degranulation and increased 
cytokine expression and neuropeptide release (288). Mast cell infiltration and 
hypertrophy of sensory innervation have been reported in biopsies from patients with 
IBS (124, 289, 290), IC (291, 292), and vulvodynia (293, 294). Involvement of transient 
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receptor potential vanilloid 1 (TRPV1), the capsaicin receptor necessary for the 
development of inflammatory hyperalgesia (136, 295), has also been shown to 
contribute toward acute stress-induced colonic hypersensitivity in NMS rats (116). 
Together these studies suggest that NMS increases the activity of the HPA axis 
resulting in central and peripheral changes underlying increased anxiety-like behaviors 
and visceral sensitivity and neurogenic inflammation.   
Stress or direct organ irritation/inflammation during early development has been 
shown to permanently enhance sensitivity and nociceptive signaling within the 
gastrointestinal (147, 149, 296-298) and urinary (299, 300) systems of rodents, 
therefore, we hypothesized that early life stress would also increase sensitivity within 
the reproductive system concordant with impaired regulation of the HPA axis. Previous 
studies of early life stress in mice have largely performed NMS only during the stress 
hyporesponsive state (postnatal day [P] 1-14) (301), and subsequently reported a mild 
anxiety-like phenotype (248), or a decrease in behavioral anxiety (243, 302, 303). In the 
current study, we compared adult female mice that underwent NMS during the first two 
weeks of life to those that underwent NMS during the entire preweaning period (P1-21), 
to determine if stress following the stress hyporesponsive state, yet still during final 
synaptic maturation within the limbic system (304), would result in a more pronounced 
phenotype.  To assess vulnerability to adult stress exposure, mice were tested for 
anxiety-like behavior and hindpaw sensitivity, both prior to and following vaginal balloon 
distension (VBD), which quantified vaginal sensitivity and was considered an acute 
stress exposure.  Protein and mRNA expression of mediators involved in regulating the 
HPA axis both centrally and peripherally, as well as protein expression of TRPV1, and 
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the related TRPA1, within the vagina, bladder, and colon were measured to determine 
how early life and adult stress may influence comorbid pelvic pain disorders.   
2.3 Materials and methods 
Animals 
 Experiments were performed on female C57Bl/6 mice (Charles River, 
Wilmington, MA) born and housed in the Research Support Facility at the University of 
Kansas Medical Center.  Mice were housed on a 12-hour light cycle from 600 to 1800 
hours and received water and food ad libitum.  All research performed conformed to the 
National Institute of Health Guide for the Care and Use of Laboratory Animals in 
accordance with the guidelines specified by the University of Kansas Medical Center 
Animal Care and Use Protocols.  
Neonatal maternal separation 
 Beginning on postnatal day 1 (P1, date of birth was considered P0), pups were 
removed daily from their home cages for 180 minutes (1100 to 1400 hours) and placed 
as a litter, with a small amount of home bedding material, into a clean glass beaker and 
held at 34°C and 50% humidity. Each litter was weighed en masse prior to and at the 
end of the separation period. NMS14 mice underwent daily separation from P1 through 
P14 and then remained undisturbed, with the exception of routine animal husbandry, in 
their home cages until weaning at P22.  NMS21 mice underwent daily separation from 
P1 through P21 and were weaned at P22.  Naïve mice were born in-house and 
remained undisturbed, with the exception of daily weighing and routine animal 
husbandry, in their home cages until weaning at P22.  Three separate cohorts of 
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NMS21 mice and two separate cohorts of NMS14 mice were used in this study.  Each 
cohort of NMS14 and NMS21 mice was compared to a corresponding naïve group of 
mice that were born, housed, and weaned during the same time frame to avoid potential 
complications arising from variations in prenatal shipping conditions, housing 
environment, and investigator handling. 
Experimental design 
 All naïve, NMS14, and NMS21 mice were subjected to vaginal balloon distension 
(VBD) as adults (between 9-36 weeks of age, Table 2.1). VBD was considered a 
stressor in these experiments, as colorectal distension (CRD) significantly elevated 
serum corticosterone levels in a separate cohort of naïve female mice (761.6  83.7 
ng/ml) compared to age-matched non-distended naïve female mice (236.8  106 ng/ml; 
p < 0.05, Mann-Whitney test, n=5). Either prior to (Baseline group) or following VBD 
(post-VBD group), mice underwent open field, thermal analgesiometer, and von Frey 
monofilament testing, as described in Table 2.1. With the exception of naïve mice in the 
NMS14 cohort, separate groups of mice were used for baseline and post-VBD 
behavioral measurements.  All mRNA and protein analysis was performed on tissue 
from the same cohort of naïve and NMS21 mice that was euthanized a week after VBD 
testing or from age-matched non-VBD exposed mice.   
Behavioral analysis 
 All mice underwent a 30-minute acclimatization period within the testing room for 
at least one day prior to each behavioral test. For both thermal and mechanical hindpaw 
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sensitivity testing, the mice were allowed to acclimate to the apparatus for 30 minutes 
prior to testing and the experimenter was blinded to the group status of the mice.   
 
 
Table 2.1  Age of mice at experimental time points. 
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Table 2.1 NMS14, NMS21, and corresponding naïve mice underwent behavioral or 
physiological testing at the above noted ages (in weeks). Mice were assessed for 
anxiety-like behaviors using an open field (OF) actimeter and/or thermal and 
mechanical hindpaw sensitivity either before (Baseline) or after (post-VBD) vaginal 
balloon distension (VBD). With the exception of the naïve mice in the NMS14 cohort, 
separate groups of mice were used for baseline and post-VBD measurements.  All 
mRNA and protein expression analysis utilized tissue from naïve and NMS21 mice 
exposed to OF and/or hindpaw measurements prior to VBD and euthanized one week 
following VBD or from naïve and NMS21 mice born and euthanized at the same time, 
but without exposure to VBD. 
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Open field testing: 
Activity in NMS14 (baseline: n=5, post-VBD: n=8), NMS21 (baseline: n=8, post-
VBD: n=8) and naïve (NMS14 cohort, baseline: n=6, post-VBD: n=8; NMS21 cohort, 
baseline: n=7, post-VBD: n=7) mice was measured using a Force Plate Actimeter  
(BASi, San Diego, CA), which consists of a rigid, low-mass horizontal plate 
(44cm×44cm) coupled to high sensitivity force transducers on each corner.  A Plexiglas 
enclosure rests a few millimeters above the plate to create a transparent enclosure, all 
of which rests within a light and sound-attenuated box. Animals were individually placed 
into the middle of the testing arena and allowed to move freely for 10 minutes. During 
this time, the software recorded the distance traveled and position of the mouse. The 
total distance traveled and percent of time spent in the perimeter (outermost 8.25cm; 
increased time spent in the perimeter is indicative of anxiety (305)) was calculated and 
binned and the data from the second 5 min bin is reported here.   
Thermal analgesiometer testing: 
NMS14 (baseline: n=5, post-VBD: n=8), NMS21 (baseline: n=8, post-VBD: n=8) 
and naïve (NMS14 cohort, baseline: n=6, post-VBD: n=8; NMS21 cohort, baseline: n=8, 
post-VBD: n=8) mice were placed in individual clear plastic chambers (11×5×3.5cm) on 
the 30C heated glass surface of a thermal analgesiometer (UARDG; Department of 
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Anesthesiology, University of California San Diego, La Jolla, CA).  A high intensity light 
(4.25 Amperes) was directed at the plantar aspect of the hindpaw and the latency to 
withdrawal from the stimulus was automatically recorded within 0.01 second. Alternating 
hindpaws were tested for a total of three times per side with a minimum of 5 minutes 
between applications. The stimulus terminated automatically at 20 seconds to avoid 
tissue damage. Individual responses were averaged together/mouse and group means 
were determined as previously described (306).  
Von Frey monofilament testing: 
NMS14 (baseline: n=4, post-VBD: n=8), NMS21 (baseline: n=8, post-VBD: n=8) 
and naïve (NMS14 cohort, baseline: n=6, post-VBD: n=7; NMS21 cohort, baseline: n=8, 
post-VBD: n=8) mice were placed into individual clear plastic chambers (11×5×3.5cm) 
on a wire mesh screen elevated 55 cm above a table. The up-down method was 
performed to test mechanical sensitivity using a standard set of von Frey monofilaments 
(1.65, 2.36, 2.83, 3.22, 3.61, 4.08, 4.31, 4.74g; Stoelting, Wood Dale, IL)(307). 
Beginning with the 3.22g monofilament, mice received a single application to the plantar 
surface of the right hindpaw. A negative response was followed by the next larger 
filament and a positive response (considered a brisk withdrawal of the paw) was 
followed by the next smaller gram filament.  The experimenter continued to move up or 
down the series, depending on the previously elicited response, for an additional four 
applications after the first positive response was observed for a minimum of five or a 
maximum of nine total monofilament applications. The value in log units of the final von 
Frey monofilament applied in the trial series was used to calculate a 50% g threshold for 
each mouse and group means were determined as previously described (308).  
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Electromyographic electrode implantation and vaginal balloon distension 
The visceromotor response (VMR) to vaginal balloon distension (VBD) was 
evaluated in adult (≥9 weeks) NMS14 (n=19) and NMS21 (n=19) mice, along with 
corresponding naïve cohorts (n=13 and 20, respectively).  Electrode implantation was 
performed as previously described (249). Under inhaled isoflurane (4% induction, 2.5% 
maintenance) and aseptic conditions, the bare ends of two Teflon-coated stainless steel 
wires (3mm; Grass Technologies, West Warwick, RI) were inserted into the right lateral 
abdominal musculature, secured via 5-0 prolene sutures, tunneled subcutaneously to a 
small incision made in the nape of the neck and externalized for access during testing.  
Skin incisions were closed using 5-0 silk suture. Following recovery from anesthesia, 
mice were housed singly and allowed to recover for a minimum of 4 days before 
undergoing testing. 
To facilitate balloon insertion and obtain proper restraint during VBD, mice were 
briefly sedated with inhaled isoflurane and a custom-made latex balloon (1cm in length) 
was inserted into the vagina and secured to the base of the tail with tape.  The mouse 
was then placed into a Broome-style rodent restraint (Kent Scientific, Torrington, CT), 
the free ends of the electrode wires were attached to a differential amplifier (Model 
1700, A-M Systems, Sequim, WA), and the mice were allowed to recover from 
anesthesia for 30 minutes.  VBD was produced by inflating the balloon with air from a 
compressed nitrogen tank equipped with a dual-stage low delivery pressure regulator 
(Matheson-Linweld, Kansas City, MO) and a separate pressure monitor (World 
Precision Instruments, Sarasota, FL) was used to regulate the pressure inside of the 
balloon.  Each pressure (40, 60, 80, 100 and 120mmHg) was applied three times for 20 
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seconds with a 4-minute rest period in between.  A custom-made distension control 
device (The University of Iowa Medical Instruments, Iowa City, IA) was used to control 
the gas flow through the system.  Electromyographic (EMG) activity was amplified, 
filtered and recorded on a personal computer with Spike 2 software (Cambridge 
Electronic Design, Cambridge, UK) for off-line analysis.  VMR was quantified by 
measuring the area under the curve for the entire distension period divided by the 
duration of the distension and expressed as a percent of baseline activity (10s prior to 
VBD). 
mRNA extraction and qRT-PCR 
 Mice were overdosed with inhaled isoflurane (>5%) and transcardially perfused 
with ice cold 0.9% saline. Brains were removed and frozen on dry ice. Hypothalamus, 
hippocampus, and amygdala were dissected, immediately snap frozen in liquid nitrogen, 
and stored at -80C. The entire length of the vagina (not including the cervix), urinary 
bladder, and 1.5cm distal segment of the colon were removed, bisected longitudinally 
(to facilitate both mRNA and protein [see below] analysis), snap frozen in liquid 
nitrogen, and stored at -80C. Total RNA was isolated from dissected tissues using 
Trizol reagent (Ambion, Austin, TX) and RNeasy Mini Kit (Qiagen, Valencia, CA). The 
concentration and purity were determined using a 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA) and cDNA was synthesized from total RNA (0.63 μg) 
using the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). Quantitative RT-PCR 
was performed using SsoAdvanced SYBR Green Supermix (Bio-Rad) and a Bio-Rad 
iCycler IQ real time PCR system with indicated 20µM primers (Integrated DNA 
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Technologies, Coralville, IA) listed in Table 2.2.  GAPDH was used as a control gene for 
brain tissues and -actin was used as a control for vagina, bladder, and colon. 
Western blot   
Table 2.2 Primers used for real-time PCR analysis 
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Total protein was isolated from approximately 50 mg of snap-frozen vagina, 
bladder, and colon using Cell Extraction Buffer (Invitrogen, Grand Island, NY) containing 
Halt protease and phosphatase inhibitors (ThermoFisher Scientific, Waltham, MA) and 
Na3VO4 (Sigma, St. Louis, MO). Protein concentrations were determined using a 
DC protein assay (ThermoFisher). Samples were reduced by heating to 95°C for 5 
minutes in the presence of 2-mercaptoethanol, subjected to SDS-PAGE (Criterion 4% to 
12% Bis-Tris gels; Bio-Rad, Hercules, CA), and transferred to Nitrocellulose transfer 
membrane (Whatman GmbH, Dassel, Germany) by Criterion Blotter wet transfer (Bio-
Rad). The membranes were blocked for 1 hour at room temperature in 5% milk in Tris-
buffered saline with Tween-20 (TBST) and incubated overnight at 4°C with antisera to 
CRF1 (1:500; Millipore, Billerica, MA), CRF2 (1:800; Millipore), TRPV1 (1:1000; Alomone 
Labs, Jerusalem, Israel), or TRPA1 (1:1000; Aviva Systems Biology, San Diego, CA) 
and GAPDH (1:2000; Cell Signaling Technology, Danvers, MA) diluted in 5% milk in 
TBST. Membranes were then washed with TBST and incubated for 1 hour with anti-
rabbit secondary antibody (1:10,000; Cell Signaling, Danvers, MA). Densitometry was 
performed using Quantity One 4.6.9 software (Bio-Rad). 
Statistics 
Calculations were made using Microsoft Excel and statistical analysis was 
performed using Student’s t-test, and 1-way or 2-way (with or without repeated 
measures) analysis of variance (ANOVA) followed by Fisher’s least significant 
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difference (LSD) or Bonferroni’s posttest (IBM SPSS Statistics, IBM Corporation, 
Armonk, NY; GraphPad Prism, GraphPad Software, La Jolla, CA), as denoted in the 
manuscript.  All data are expressed as mean  SEM.  A p value of less than 0.05 was 
considered significant. 
2.4 Results 
NMS for 21 days impacts vaginal sensitivity 
 The effect of NMS and length of separation on vaginal sensitivity was determined 
by measuring the VMR during VBD in adult female NMS14, NMS21, and corresponding 
naïve mice.  Similar to VMR during colorectal distension (149), the EMG activity of the 
abdominal musculature significantly increased in response to greater intraballoon 
pressure applied within the vagina (Figure 2.1A-B).  NMS14 mice did not display 
significantly increased vaginal sensitivity compared to naïve counterparts (Figure 2.1C).  
In contrast, NMS21 mice had significantly greater VMR over the entire distension series 
than their naïve counterparts and at every individual pressure beyond the lowest in 
posthoc comparison (Figure 2.1D).  
NMS and VBD affect anxiety-like behaviors 
To determine the effect of NMS and length of separation on anxiety-like behavior, 
female NMS14, NMS21 and corresponding naïve mice were subjected to open field 
testing on a force plate actimeter to measure exploratory behavior either prior to or 
following VBD. NMS14 mice did not differ significantly from naïve mice with regards to 
time spent in the perimeter of the open field, either prior to or following VBD (Figure 
2.2A).  In contrast, NMS21 mice displayed significantly reduced anxiety-like behaviors 
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at baseline, measured as less time spent in the perimeter of the open field (Figure 
2.2B). Following VBD, NMS21 mice spent significantly more time in the perimeter of the  
Figure 2.1 
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Figure 2.1 Vaginal sensitivity was significantly affected by neonatal maternal separation 
(NMS). The visceromotor response (VMR) of NMS14 (A), NMS21 (B), and 
corresponding naïve mice was measured by recording the electromyographic (EMG) 
activity of the abdominal musculature during graded balloon distension of the vagina 
(VBD).  C) No significant difference in VMR was determined between NMS14 and naïve 
mice (p > 0.05). D) NMS21 mice had a significantly higher VMR than naïve mice over 
the entire distension series (p < 0.01), as well as at every pressure above the lowest 
applied. *,**,***p < 0.05, 0.01, 0.001, two-way RM ANOVA and Fisher’s LSD. 
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Figure 2.2.  
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Figure 2.2  Anxiety-like behavior and hindpaw sensitivity were dose-dependently 
affected by neonatal maternal separation (NMS) and vaginal balloon distension (VBD). 
The percent of time spent in the perimeter of an open field actimeter was recorded as a 
measure of behavioral anxiety in NMS14 (A), NMS21 (B), and corresponding naïve 
mice, both prior to (Baseline) and following VBD (Post-VBD). A) No significant effect of 
NMS or VBD on exploratory behavior was observed within the NMS14 group. B) 
NMS21 mice displayed a significant decrease in the percent of time spent in the 
perimeter of the open field at baseline compared to naïve mice. Following VBD, NMS21 
mice spent a significantly larger percentage of their time in the perimeter compared to 
both post-VBD naïve mice and baseline NMS21 mice. C) The withdrawal latency of the 
hindpaw to a thermal stimulus was significantly shorter in NMS14 mice only following 
VBD, compared to both post-VBD naïve and NMS14 baseline measurements.  D) 
NMS21 mice displayed a significantly shorter withdrawal latency to thermal stimulation 
of the hindpaw than naïve mice, both at baseline and post-VBD. E) The withdrawal 
threshold of the hindpaw to a mechanical stimulus was significantly lower in NMS14 
mice only following VBD, compared to post-VBD naïve mice. F) NMS21 mice also 
displayed a significantly lower withdrawal threshold to mechanical stimulation of the 
hindpaw than naïve mice, both at baseline and post-VBD. *p < 0.05, **p < 0.01, ***p < 
0.001, ****p < 0.0001 vs. naïve, ##p < 0.01, ####p < 0.0001 vs. baseline; two-way ANOVA 
and Bonferroni posttest. 
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open field than naïve mice or baseline NMS21 measurements, indicating an increase in 
anxiety-like behaviors (Figure 2.2B). 
Length of NMS affects hindpaw sensitivity 
The impact of NMS and length of separation on hindpaw thermal and mechanical 
sensitivity was determined either prior to or following VBD.  At baseline, NMS14 mice 
showed no significant difference in thermal or mechanical hindpaw sensitivity compared 
to naïve counterparts (Figure 2.2C, E). Following VBD, NMS14 mice displayed 
significantly reduced thermal withdrawal latencies and mechanical withdrawal 
thresholds, compared to naïve counterparts (Figure 2.2C, E), indicative of 
hypersensitivity.  In comparison, NMS21 mice had significantly lower thermal withdrawal 
latencies and mechanical withdrawal thresholds both at baseline and following VBD, 
compared to naïve counterparts (Figure 2.2D, F). VBD had no significant effect on naïve 
thermal (Figure 2 2C-D) or mechanical (Figure 2.2E-F) hindpaw sensitivity in either 
cohort.   
NMS and VBD disrupted regulatory gene expression of the HPA axis 
 To determine the impact of NMS and VBD on gene expression within central 
structures involved in the regulation and output of the HPA axis, we used RT-PCR to 
measure CRF, Ucn2, CRF1, CRF2, GR, and MR mRNA levels in the hypothalamus, 
amygdala, and hippocampus of naïve and NMS21 mice with and without exposure to 
VBD. In the hypothalamus, NMS had a significant effect on increasing CRF and GR 
mRNA levels, as well as inducing a trend towards increased Ucn2 and CRF1 mRNA 
levels (Figure 2.3A). NMS, as well as VBD, significantly decreased the level of CRF2  
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Figure 2.3 
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Figure 2.3  Neonatal maternal separation (NMS) and vaginal balloon distension (VBD) 
significantly impacted negative regulatory feedback onto the hypothalamic-pituitary-
adrenal (HPA) axis. Gene expression was measured by RT-PCR in the hypothalamus 
(A), amygdala (B), and hippocampus (C) of naïve and NMS21 mice that either did not 
(Naïve-ND and NMS21-ND) or did undergo VBD (Naïve-VBD and NMS21-VBD). A) In 
the hypothalamus, NMS significantly increased CRF and GR mRNA expression and 
induced a trend towards increased Ucn2 and CRF1 mRNA expression.  NMS and VBD 
both significantly decreased CRF2 mRNA expression with NMS21-ND and naïve-VBD 
expressing significantly less CRF2 mRNA than naïve-ND. B) NMS caused a trend 
towards decreased CRF2 mRNA expression in the amygdala (p = 0.051). C) In the 
hippocampus, NMS significantly decreased the mRNA expression of CRF2 and GR with 
NMS21-ND expressing significantly less GR mRNA than naïve-ND, whereas VBD 
significantly increased CRF2 mRNA expression with naïve-VBD expressing significantly 
more CRF2 mRNA naïve-ND. NMS and VBD had a significant interaction effect on 
decreasing MR mRNA expression in the hippocampus with NMS21-ND and naïve-VBD 
both expressing significantly less MR than naïve-ND. Housekeeping gene: -actin. 
Brackets indicate significant impact of NMS (*,**p <0.05, 0.01), VBD (#,##p < 0.05, 0.01) 
or an NMS/VBD interaction (+p < 0.05), two-way ANOVA; *p < 0.05 vs. naïve, # p < 0.05 
vs. baseline, Bonferroni posttest. 
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mRNA in the hypothalamus, with non-distended NMS21 mice and post-VBD naïve mice 
both expressing significantly less CRF2 mRNA than non-distended naïve mice (Figure 
2.3A). In the amygdala, only CRF2 was affected by NMS with a trend towards 
decreased expression (Figure 2.3B). In the hippocampus, NMS significantly decreased 
the mRNA levels of CRF2 and GR (Figure 2.3C). In opposition to the effect of VBD on 
CRF2 in the hypothalamus, VBD had a significant impact on increasing CRF2 mRNA 
levels in the hippocampus, particularly in naïve mice (Figure 2.3C). NMS and VBD had 
a significant interaction effect on MR mRNA levels in the hippocampus, with non-
distended NMS21 mice and post-VBD naïve mice both expressing significantly less MR 
mRNA than non-distended naïve mice (Figure 2.3C).  
NMS and VBD impact adult vaginal inflammatory mediator, CRF receptor, and TRP 
channel expression patterns 
 We performed RT-PCR to determine mRNA levels of inflammatory mediators 
shown to be affected by NMS (309-311) and Western blotting to determine the potential 
contribution of peripheral CRF receptor and TRP channel protein expression on vaginal 
sensitivity following NMS and/or VBD. NMS alone did not significantly impact 
inflammatory mediator expression within the vagina. However, NMS and VBD had a 
significant interaction effect on both IL10 and TNF mRNA levels, with post-VBD 
NMS21 mice expressing significantly higher levels of both genes than post-VBD naïve 
mice (Figure 2.4A). VBD was shown to significantly impact Artemin (Art) mRNA levels, 
with post-VBD NMS21 mice expressing significantly higher levels of Art mRNA than 
non-distended NMS21 mice. NMS and VBD also had a significant interaction effect on 
CRF1 protein expression in the vagina, with post-VBD NMS21 mice expressing  
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Figure 2.4 
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Figure 2.4 Neonatal maternal separation (NMS) and vaginal balloon distension (VBD) 
significantly disrupted gene and protein expression within the vagina. RT-PCR (A) and 
Western blot (B-C) was performed on vagina from naïve and NMS21 mice that either 
did not (Naïve-ND and NMS21-ND) or did undergo VBD (Naïve-VBD and NMS21-VBD). 
A) NMS and VBD had a significant interaction effect on IL10 mRNA expression with 
NMS21-VBD expressing significantly more IL10 mRNA than NMS21-ND or naïve-VBD. 
NMS and VBD also had a significant interaction effect on TNF mRNA expression with 
NMS21-VBD expressing significantly more TNF mRNA than naïve-VBD. VBD 
significantly increased Artemin (Art) mRNA expression with NMS21-VBD expression 
significantly more Art than NMS21-ND. IL6 and nerve growth factor (NGF) transcripts 
were not affected by either NMS or VBD. B) Representative Western blots are shown 
for CRF1, CRF2, and corresponding GAPDH protein expression with bands at 55, 47, 
and 35kD, respectively. NMS and VBD had a significant interaction effect on CRF1 
protein expression in the vagina with NMS21-VBD expressing significantly less CRF1 
protein than naïve-VBD. CRF2 protein expression in the vagina was unaffected by NMS 
or VBD.  C) Representative Western blots are shown for TRPV1, TRPA1, and 
corresponding GAPDH protein expression with bands at 85, 127, and 35kD, 
respectively. VBD significantly decreased the protein expression of both TRPV1 and 
TRPA1 in the vagina. Naïve-VBD and NMS21-VBD both expressed significantly less 
TRPV1 than their non-distended counterparts. NMS21-VBD also expressed significantly 
less TRPA1 protein than NMS21-ND. Housekeeping gene: GAPDH (A). Brackets 
indicate significant impact of VBD (#,####p < 0.05, 0.0001) or an NMS/VBD interaction 
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(+,++p < 0.05, 0.01), two-way ANOVA; *,**p < 0.05, 0.01 vs. naïve, #,### p < 0.05, 0.001 
vs. baseline, Bonferroni posttest. 
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significantly less CRF1 protein than post-VBD naïve mice (Figure 2.4B).  Despite being 
significantly altered in central structures, the protein expression of CRF2 was not altered 
by either NMS or VBD in the vagina (Figure 2.4B). NMS also did not affect protein 
expression of TRPV1 or TRPA1 in the vagina; however VBD significantly decreased the 
expression of both proteins compared to non-distended counterparts (Figure 2.4C).  
Influence of NMS and VBD on inflammatory mediator, CRF receptor, and TRP channel 
expression patterns in the bladder and colon 
 Up to 50% of women with chronic pelvic pain experience symptoms from more 
than one disorder (7, 13, 17-22). To determine how NMS and VBD impact neighboring 
viscera, which have been shown to be affected by early adverse events (147, 149, 296, 
300), we performed RT-PCR to measure mRNA levels of inflammatory mediators and 
Western blotting to assess CRF receptor and TRP channel protein expression in the 
bladder and colon. In the bladder, NMS significantly increased IL10 and NGF mRNA 
levels and VBD significantly decreased IL6 mRNA (Figure 2.5A). In the colon, only a 
trend towards NMS-induced increased IL10 mRNA levels was observed. Peripheral 
CRF receptor expression was differentially affected in the bladder and colon by NMS 
and VBD (Figure 2.6A). In the bladder, CRF1 protein expression was significantly 
increased by VBD with post-VBD NMS21 bladder expressing significantly more CRF1 
than non-distended NMS bladder (Figure 2.5B). CRF1 protein expression was not 
impacted by NMS or VBD in the colon; however NMS and VBD had a significant 
interaction effect on CRF2 in the colon with non-distended NMS21 expressing 
significantly more CRF2 protein than non-distended naïve or post-VBD NMS21 (Figure 
2.6B). As in vagina, TRPV1 protein expression was significantly decreased post-VBD in  
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Figure 2.5  Neonatal maternal separation (NMS) and vaginal balloon distension (VBD) 
significantly disrupted gene and protein expression within the bladder. RT-PCR (A) and 
Western blot (B-C) was performed on bladder from naïve and NMS21 mice that either 
did not (Naïve-ND and NMS21-ND) or did undergo VBD (Naïve-VBD and NMS21-VBD). 
A) NMS significantly increased both IL10 and nerve growth factor (NGF) mRNA 
expression. VBD significantly decreased IL6 mRNA expression. Neither NMS nor VBD 
had a significant effect on TNF or Artemin (Art) mRNA expression in the bladder. B) 
Representative Western blots are shown for CRF1, CRF2, and corresponding GAPDH 
protein expression with bands at 55, 47, and 35kD, respectively. VBD significantly 
increased CRF1 protein expression in the bladder with NMS21-VBD expressing 
significantly more CRF1 protein than NMS21-ND. CRF2 protein expression in the 
bladder was not significantly affected by either NMS or VBD.  C) Representative 
Western blots are shown for TRPV1, TRPA1, and corresponding GAPDH protein 
expression with bands at 85, 127, and 35kD, respectively. TRPV1 protein expression in 
the bladder was significantly affected by VBD alone and by an interaction effect of NMS 
and VBD. NMS21-VBD bladder expressed significantly less TRPV1 than either NMS21-
ND or naïve-VBD bladder and naïve-VBD expressed significantly less TRPV1 than 
naïve-ND bladder. In contrast, TRPA1 protein expression was significantly increased by 
VBD and there was also a significant interaction effect of NMS and VBD.  Naïve-VBD 
bladder expressed significantly more TRPA1 than naïve21-ND bladder. Housekeeping 
gene: GAPDH (A). Brackets indicate significant impact of NMS (*p < 0.05), VBD 
(#,##,####p < 0.05, 0.01, 0.0001) or an NMS/VBD interaction (+,++p < 0.05, 0.01), two-way 
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ANOVA; **p < 0.01 vs. naïve, #,##,#### p < 0.05, 0.01, 0.0001 vs. baseline, Bonferroni 
posttest. 
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Figure 2.6  
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Figure 2.6  Neonatal maternal separation (NMS) and vaginal balloon distension (VBD) 
significantly disrupted protein expression within the colon. RT-PCR (A) and Western 
blot (B-C) was performed on colon from naïve and NMS21 mice that either did not 
(Naïve-ND and NMS21-ND) or did undergo VBD (Naïve-VBD and NMS21-VBD). A) 
NMS only had a moderate effect on mRNA expression in the colon, with a trend towards 
increased IL10 mRNA expression in NMS21 colon. Neither NMS nor VBD had a 
significant effect on IL6, TNF, Artemin (Art), or nerve growth factor (NGF) mRNA 
expression in the colon. B) Representative Western blots are shown for CRF1, CRF2, 
and corresponding GAPDH protein expression with bands at 55, 47, and 35kD, 
respectively. NMS and VBD had a significant interaction effect on CRF2 protein 
expression in the colon with NMS21-ND expressing higher CRF2 protein than both 
naïve-ND and NMS21-VBD colon. CRF1 protein expression in the colon was not 
significantly affected by either NMS or VBD.  C) Representative Western blots are 
shown for TRPV1, TRPA1, and corresponding GAPDH protein expression with bands at 
85, 127, and 35kD, respectively. Similar to its effects on vagina and bladder, VBD 
significantly decreased TRPV1 protein expression in the colon with naïve-VBD 
expressing significantly less TRPV1 than naïve-ND colon. NMS and VBD both 
separately induced a significant increase in TRPA1 protein expression in the colon. 
NMS21-ND colon expressed significantly more TRPA1 protein than naïve-ND colon. 
Housekeeping gene: GAPDH (A). Brackets indicate significant impact of NMS (*p < 
0.05), VBD (#p < 0.05) or an NMS/VBD interaction (++p < 0.01), two-way ANOVA; *p < 
0.05 vs. naïve, # p < 0.05 vs. baseline, Bonferroni posttest. 
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both bladder and colon (Figure 2.5C and 2.6C). An additional significant interaction 
effect of NMS and VBD was observed on TRPV1 expression in the bladder with NMS21 
post-VBD bladder expressing significantly less TRPV1 than naïve post-VBD bladder 
(Figure 2.5C). TRPA1 protein expression was differentially affected by NMS and VBD in 
bladder and colon. In the bladder, a significant effect of VBD and a significant 
interaction effect of NMS and VBD on TRPA1 protein expression was observed with 
naïve post-VBD bladder expressing significantly more TRPA1 protein than non-
distended naïve bladder (Figure 2.5C). In the colon, NMS significantly increased TRPA1 
protein expression, while VBD significantly decreased TRPA1 protein expression 
(Figure 2.6C). 
2.5 Discussion 
 Patients suffering from chronic pelvic pain syndromes, particularly IBS, IC/PBS, 
and vulvodynia, commonly report that stress initiates or exacerbates existing symptoms 
(7, 17, 282).  A history of early adverse events increases the likelihood of diagnosis of 
one or more of these pain syndromes, as well as comorbidity with depression and/or 
anxiety (275-278).  The current study demonstrates that early life stress has a dose 
response-like effect on vaginal and hindpaw sensitivity and anxiety-like behaviors in 
adult female mice. Changes in mRNA and protein expression related to the regulation 
and output of the HPA axis may underlie these behavioral outcomes. 
Clinical evidence suggests a strong link between child abuse or neglect and the 
development of vulvodynia in adulthood (21, 278, 312-314).  A recent study reported 
that patients with provoked vestibulodynia have a lower vaginal distension threshold 
than control patients, suggesting that vulvodynia may be associated with vaginal 
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allodynia (315). In the current study, mice that experienced the greatest amount of 
neonatal stress − in the form of NMS for 21 days, displayed robust vaginal allodynia by 
generating a significantly enhanced VMR at every intraballoon pressure greater than the 
lowest applied. This response differs markedly from what we (149) and others (298, 
299, 316) have observed following neonatal irritation or inflammation in the pelvic 
viscera where VMR was generally increased only at the highest applied pressures.  An 
earlier study of colorectal sensitivity in NMS rats reported an increase in VMR at both 
low and high intraballoon pressures following acute water avoidance stress (146), which 
has been shown to impact visceral sensitivity (317, 318). The difference in outcomes 
between NMS and neonatal visceral irritation/inflammation likely involves recruitment of 
higher structures involved in regulating the HPA axis. The lack of effect of NMS for 14 
days on vaginal sensitivity was striking considering a recent publication by Maloney et 
al., (319), that demonstrated increased VMR during colorectal distension in male mice 
that underwent maternal separation combined with unpredictable maternal stress from 
P1-14. It is likely that variances in the neonatal stress paradigm used, organs of 
interest, and the sex of the mice that were studied underlie the observed differences 
between the two studies.  
To our knowledge, this is the first report of measuring VMR to quantify 
physiological responses to graded distension of the vagina in conscious mice. Previous 
studies by Berkley, et al., have measured escape behaviors in awake rats (320), as well 
as VMR in anesthetized rats (321), in response to VBD, and demonstrated significant 
effects of estrous cycle (322) and cyst burden and innervation (323, 324) in an 
experimental model of endometriosis. Miranda et al. (325), also reported an estrous 
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cycle effect on VMR during colorectal distension in awake rats that received 
intravesicular zymosan as neonates to induce cystitis.  Importantly, both studies 
reported that the effect of the experimental treatment was large enough to negate the 
estrous cycle effect.  Based on these observations and the unknown effect of collecting 
vaginal smears on vaginal sensitivity in NMS mice, the estrous cycle of the mice in this 
study was unknown. 
The observations of the impact of NMS on hindpaw sensitivity are novel, as 
previous studies have shown either no impact (326) or a decrease (327) in thermal 
hindpaw sensitivity in adult female NMS rats. No literature could be found assessing 
thermal hindpaw sensitivity in mice or mechanical hindpaw thresholds in either rodent 
species following NMS. Viscero-somatic convergence between the hindpaw and 
bladder or colon has been previously demonstrated following inflammation of either 
organ (328, 329) or the hindpaw (328) of adult rodents.  Neonatal irritation of the colon 
(149), bladder (300) or vagina (unpublished observation, manuscript in preparation), 
has been shown to have differential effects on hindpaw sensitivity, suggesting that the 
nature, location, and timing of an early adverse event can dramatically affect the 
outcome of considered “secondary” symptomology. Vaginal and/or cervical stimulation 
has previously been shown to be antinociceptive and decrease hindpaw sensitivity 
and/or completely block hindpaw withdrawal from noxious stimuli (330). However, these 
measurements were taken during vaginal/cervical stimulation and not as a 
consequence of the stress generated during the visceral stimulation, therefore cervical 
stimulation likely did not influence the observations in the current study.   
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Stressful events experienced early in life can greatly increase the likelihood of 
developing anxiety- or depression-like symptoms during adulthood (230, 331). NMS in 
rats has generally been shown to increase anxiety-like behaviors and the duration of 
ACTH and corticosterone release following a stressful event (64, 241, 242), whereas 
NMS in mice has been shown to generate a mild anxiety-like phenotype (248), or 
decrease behavioral anxiety (302, 303, 332). In the current study, we observed no 
change in anxiety-like behavior in NMS14 mice and a decrease in anxiety-like behavior 
in NMS21 mice at baseline, which was reversed following VBD.  There was an 
observable difference in anxiety-like behavior between the two naïve groups that 
corresponded to the NMS14 and NMS21 mice. Considering that corresponding naïve 
mice were weighed daily at the time of separation, the additional week of brief daily 
separations experienced by the NMS21 naïve group may have contributed to this 
difference, as brief daily separations have been shown to reduce anxiety-like behaviors 
(333). This observation illustrates the importance of testing corresponding naïve and 
NMS groups to control for differences in environmental stressors that may influence 
behavioral outcomes. Changes in gene expression within the hypothalamus of NMS 
mice, both at baseline and following VBD, suggest that increased HPA output, resulting 
from diminished negative feedback, may underlie the increase in anxiety-like behaviors. 
NMS simultaneously increased CRF and decreased CRF2 mRNA levels. The trend 
towards an increase in Ucn2 mRNA in NMS21 mice may be a compensatory action, as 
VBD also decreased CRF2 mRNA in naïve mice, but did not show a corresponding 
increase in Ucn2. GR was also increased in NMS21 hypothalamus, which could be a 
compensatory response to decreased hippocampal GR expression (334) or GR 
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resistance (93). Up-regulation of both CRF1 protein expression (287) and binding (242) 
in the hypothalamus of NMS rats has been previously reported and supports our 
findings here.  
The greater impact of the three week-long NMS period on all behavioral and 
physiological measurements in the current study, compared to the standard two week-
long NMS period, may be due to disruption of proper limbic structure maturation. The 
peak period of hippocampal neurogenesis overlaps with the stress hyporesponsive 
period (P1-14) (335); however, mature firing patterns do not emerge until the third 
postnatal week (304).  Limbic structures have been shown to influence pain and anxiety 
through HPA- and non-HPA-mediated mechanisms. Systemic and local corticosterone 
production increases CRF expression in the CeA of the amygdala through a GR-
dependent mechanism (92). The level of CRF expression within the amygdala has been 
shown to mediate pain effects, which can be blocked by CRF1 antagonist treatment, but 
not CRF2 antagonist (336). This observation was supported by earlier work 
demonstrating that basal CRF1 signaling contributes to pain-related synaptic facilitation 
and CRF2 exerts a latent inhibitory influence (337). Observations in the current study 
support this earlier work, as a trend toward decreased CRF2 mRNA expression was 
detected in amygdala of NMS mice, suggesting that a loss of inhibition within the 
amygdala could be contributing towards the increase in vaginal sensitivity and anxiety-
like behaviors. Hippocampal inhibition of the HPA axis can be compromised by chronic 
stress or long-term high dose corticosteroid treatment, resulting in decreased GR 
expression (65). Observations in the current study support this mechanism, as NMS 
significantly decreased both GR and MR protein expression in the hippocampus, 
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potentially compromising hippocampal inhibition of the HPA axis. Acute adult stress, in 
the form of VBD, also significantly impacted mRNA levels in the hippocampus, 
specifically increasing CRF2 and decreasing MR levels.  The increase in CRF2 mRNA 
levels was likely compensatory in response to either heightened HPA output or 
decreased hippocampal MR levels following VBD. The lack of a similar increase in 
CRF2 in NMS21 hippocampus suggests potential disruption in proper limbic response 
following acute stress.  A prolonged decrease in hippocampal MR expression has been 
previously reported to occur following a single sustained acute stress in rats and has 
been theorized to contribute to post-traumatic stress disorder (338).  
Up to 50% of women with chronic pelvic pain experience symptoms from more 
than one disorder, creating a greater negative impact on quality of life and complicating 
already less-than-optimal treatment strategies (7, 13, 17-22). A potential role for CRF in 
comorbidity has been established for psychological and chronic pain disorders. A 
significant correlation has been observed between IBS and depression/anxiety in 
patients with high cortisone levels (339). Epidemiological studies have also found a link 
between anxiety and voiding disorders (340); and IC/PBS patients with concomitant 
comorbid diagnoses of fibromyalgia, chronic fatigue syndrome, or rheumatoid arthritis 
had a higher mean afternoon cortisol level and increased pain during bladder filling than 
IC/PBS patients with no additional diagnoses (341). Downstream propagation of 
neurogenic inflammation resulting from dysregulation of the HPA axis has been 
proposed as a possible underlying mechanism for numerous functional pain syndromes 
(288). In the current study, we observed significant effects of NMS, VBD, and interaction 
effects of both on all three visceral structures. Examination of mRNA levels of genes 
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previously shown to be affected by NMS or involved in mediating pelvic hypersensitivity 
(309-311, 342, 343) revealed possible disruption of downstream HPA axis effects. For 
example, NMS and VBD had a significant interaction effect on IL10 and TNF mRNA 
levels in the vagina, which resulted in a significant increase in NMS21 vagina post-VBD, 
but not in naïve vagina. The lack of baseline changes in NMS21 vagina suggests that 
the response to acute stress in these animals is altered, compared to that in naïve mice, 
producing an altered downstream local cytokine response to VBD. This observation is 
supported by the significant interaction effect of NMS and VBD on CRF1 protein 
expression in the vagina, where naïve vagina showed a trend toward increased CRF1 
protein expression, which was significantly lower in NMS21 vagina, suggesting 
dysregulation of peripheral CRF receptor expression. Cytokine and growth factor mRNA 
levels were also significantly altered by NMS and VBD, separately, in the bladder.  With 
the exception of NMS producing a significant increase in NGF mRNA levels, the impact 
of NMS on IL10 levels and VBD on IL6 levels was largely anti-inflammatory, suggesting 
that these interventions may result in lowered bladder sensitivity. Spinally-administered 
CRF2 antagonist was shown to reverse stress-induced bladder sensitivity in the rat, 
whereas CRF1 antagonist had no effect (144), however, the role of peripheral CRF 
receptors in bladder sensitivity has not yet been established. Future studies will 
determine whether the increase in CRF1 protein expression in the bladder inhibits or 
drives bladder sensitivity following acute stress. The expression pattern of CRF2 in the 
colon was similar to that reported by O’Malley et al., (344), which showed a baseline 
increase in CRF2 protein expression in NMS rats that was reversed by open field stress. 
However, they also reported a similar effect on CRF1 protein expression, which was not 
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evident in our study; however, the species studied, length of NMS, and nature of the 
adult stressor likely contributes to this discrepancy. It is unclear whether the VBD effect 
on expression changes resulted from stress or from a physiological response to organ 
distension. Due to the close proximity of the investigated pelvic organs, it is possible 
that pressure exerted onto the bladder and colon during VBD could have impacted gene 
expression within these organs, as well. Regardless, these data support that NMS and 
VBD have effects on the vagina, as well as on the immediately adjacent viscera. 
The TRP family of receptors has been shown to contribute towards acute 
inflammatory colorectal hypersensitivity (135, 138, 345), as well as to colonic 
hypersensitivity resulting from neonatal colon insult (149, 298).  Local upregulation of 
TRPA1 and/or TRPV1 protein expression has also been reported following acute 
inflammation of the colon (346, 347) and bladder (348).  In non-distended mice, we only 
observed a significant increase in TRPA1 protein expression in NMS colon. However, 
VBD had a significant effect on TRPV1 and TRPA1 protein expression in every tissue 
type examined. VBD significantly decreased TRPV1 protein expression in naïve and 
NMS vagina, bladder and colon; and NMS and VBD had a significant interaction effect 
on decreasing TRPV1 expression in bladder. VBD had a similar effect on TRPA1 
protein expression in the vagina and colon; however, VBD significantly increased 
TRPA1 protein expression in the bladder, most prominently in naïve bladder. Although, 
bladder and colon sensitivity were not assayed in the current study, it is likely that TRP 
channel expression did not contribute towards the observed vaginal hypersensitivity in 
the NMS21 mice. It is striking that distension of an adjacent organ would significantly 
decrease TRPV1 protein expression in both bladder and colon. Future studies assaying 
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less invasive forms of stress will address whether this and the aforementioned 
expression changes were due to potential physical deformation of the tissue or if they 
were truly stress-mediated.    
2.6 Conclusion 
 This study provides evidence that early life stress in female mice has significant 
effects on vaginal sensitivity, anxiety-like behaviors, and central and peripheral 
expression of mediators involved in the regulation and output of the HPA axis. Exposure 
to neonatal stress had a dose response-like effect on most behavioral outcomes, which 
were further enhanced by exposure to adult stress in the form of VBD. Together with 
previous studies on the effect of NMS on psychological disturbances and pelvic organ 
sensitivity, the findings here demonstrate that neonatal stress in females can impact 
adult pain processing associated not only with the bladder and colon, but also with the 
reproductive tract and may provide a potential mechanism for the development of 
comorbid chronic pelvic pain syndromes.  
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Chapter 3 
 
Urinary bladder-specific increase in sensitivity and dysregulation of the 
hypothalamic-pituitary-adrenal axis following early life and adult stress in female 
mice. 
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3.1 Abstract 
 Early adverse events, such as childhood trauma, neglect, or abuse have been 
shown to increase the incidence of interstitial cystitis/painful bladder syndrome (IC/PBS) 
in adulthood, a syndrome that is nine times more common in women than in men.  
Despite high clinical relevance and reports of stress-related symptom exacerbation, 
animal models investigating the contribution of early life stress to female urological pain 
are lacking.  We examined the impact of neonatal maternal separation (NMS), a model 
of early life stress, on bladder sensitivity both prior to, and following, water avoidance 
stress (WAS) in adult female mice. C57Bl/6 mice were born in-house and were either 
separated as litters from their dams for 3 hours/day from postnatal day 1-21 (NMS mice) 
or remained undisturbed (naïve mice).  Bladder mast cell degranulation, as well as 
protein and mRNA expression related to neuroimmune interactions, was evaluated 
using toluidine blue staining, Western blot, and RT-PCR, respectively. Compared to 
naïve mice, NMS mice demonstrated bladder hypersensitivity that was robustly 
exacerbated by WAS.  Protein expression of protease activated receptor-2 (PAR2) and 
transient receptor potential ankyrin 1 (TRPA1), receptors involved in facilitating 
neurogenic inflammation through mast cell proteases, were increased in the bladder of 
NMS mice.  Consequently, WAS increased bladder mast cell degranulation in NMS 
mice as well as mRNA expression of cytokines and growth factors involved in facilitating 
inflammation or neuroimmune interactions.  In brain regions that regulate the HPA axis, 
altered expression of receptors or stress ligands suggested diminished negative 
feedback and glucocorticoid resistance that resulted in increased corticosterone 
secretion in NMS animals.  Mechanistically, mast cell-mediated neurogenic 
73 
 
inflammation downstream of a dysregulated HPA axis could be driving bladder 
hypersensitivity and predispose NMS mice to an aberrant response to acute stress.  
Together, this project identifies a novel impact of early life stress on adult female 
urological pain. 
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3.2 Introduction 
Stress can have dichotomous effects on pain signaling.  In instances of acute 
stress the effect can be to diminish the perception of pain, termed stress-induced 
hypoalgesia (318). However, when stress becomes chronic, increased circulation of 
glucocorticoids and dysregulation of higher systems controlling the stress response 
pathway can initiate or increase the perception of pain (349).  Patients with chronic 
pelvic pain commonly report stress-related symptom onset or increased severity, have 
difficulty coping with stressful situations, and many suffer from depression, anxiety, and 
panic disorder (7, 13, 17). Comorbidity among chronic pelvic pain syndromes and mood 
disorders has been associated with altered functioning of the hypothalamic-pituitary-
adrenal (HPA) axis, which regulates the stress response and influences the perception 
of pain (65, 350).  Exposure to early life stress or trauma is a significant risk factor for 
developing HPA axis abnormalities and associated chronic pain syndromes (265, 266).  
As such, a significant subset of patients with chronic pelvic pain disorders report having 
experienced adverse childhood events such as abuse or neglect (279-281).  
Regulation of the HPA axis occurs both within the hypothalamus, which initiates 
the stress response by secreting corticotropin-releasing factor (CRF), and from higher 
limbic structures, including the hippocampus (65). This regulation largely occurs through 
activation of the CRF receptors, which work in opposition of one another to drive (CRF1) 
and dampen (CRF2) HPA axis output (351), as well as by glucocorticoid-driven 
feedback through glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) 
(79). Downstream of chronic HPA axis activation, neurogenic inflammation may be 
promoted through mast cell degranulation and associated sensitization of transient 
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receptor potential ankyrin 1 (TRPA1) (126, 139, 142) resulting in altered cytokine 
profiles (352) and continuous cell signaling of the neuroimmune axis in the viscera 
(353).  In fact, biopsy findings support evidence of increased mast cell degranulation 
within the involved pelvic organ among patients diagnosed with irritable bowel 
syndrome (IBS) (124, 289, 290), vulvodynia (293, 294), or interstitial cystitis/painful 
bladder syndrome (IC/PBS) (291, 292).  Rodent models of neonatal stress display 
disruption of proper feedback onto the HPA axis, resulting in visceral hyperalgesia, 
permanent changes in central and peripheral pain processing, and increased peripheral 
expression of inflammatory mediators (reviewed in (354)).  The effect of early life stress 
has been well described in the gastrointestinal system (146, 230, 265, 311, 355) and 
data presented in chapter 2 provide evidence of altered sensitivity within the 
reproductive system (150); however, despite extensive characterization of the long-term 
effect of postnatal bladder inflammation (299, 300, 316, 356-358), the impact of early 
life stress on urinary bladder sensitivity and function has largely gone unstudied 
particularly in female models. 
Using a model of neonatal maternal separation (NMS), we investigated the 
impact of early life stress on gene expression in the hypothalamus and hippocampus 
and downstream pelvic organ sensitivity and function both prior-to, and following, an 
acute water avoidance stress (WAS) in adulthood.   To understand whether our findings 
were pelvic organ-specific or due to a global change in pain processing, we also 
evaluated colorectal sensitivity as a function of the same stressful conditions.  Mast cell 
degranulation and infiltration was quantified, while mRNA expression of cytokines, 
growth factors and protein expression of the tryptase receptor PAR2 and TRPA1 were 
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evaluated in the pelvic organs.  Finally, expression of factors regulating the HPA axis 
from the hypothalamus and hippocampus were measured in NMS and naïve animals at 
baseline and following WAS.  The central hypothesis of this study is that NMS results in 
altered bladder function and increased sensitivity and enhances susceptibility to stress-
induced behavioral changes in adult female mice.  Together, these results increase the 
understanding of how early life stress predisposes an individual to developing bladder 
pain syndromes during adulthood.  
3.3 Materials and methods 
Animals 
Experiments were performed on female C57Bl/6 mice (Charles River, 
Wilmington, MA) born and housed in the Research Support Facility at the University of 
Kansas Medical Center at the indicated ages in Table 3.1. Mice were housed on a 12-h 
light cycle from 600 to 1800h and received water and food ad libitum. All research 
performed conformed to the National Institute of Health Guide for the Care and Use of 
Laboratory Animals in accordance with the guidelines specified by the University of 
Kansas Medical Center Animal Care and Use Protocols. 
Neonatal Maternal Separation 
All mice used in this study were born in house from pregnant dams (Charles 
River, Wilmington, MA) delivered to the animal facility during the last week of gestation.  
Day of birth was designated as postnatal day (P) 0 and from P1 until P21 individual  
 
Table 3.1 Age of mice at experimental time points 
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Table 3.1 NMS and corresponding naïve mice underwent behavioral testing at the 
above ages noted in weeks. Each row represents different cohorts of animals that were 
exposed to the stated behavioral test (micturition analysis, urinary bladder distension 
[UBD], and colorectal distension [CRD]) or euthanized for tissue collection.  Tissue 
utilized for mRNA/protein expression, corticosterone (CORT) concentration, and the 
mast cell degranulation assay were taken from naïve and NMS mice that had not 
previously undergone behavioral testing. 
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litters were removed daily and placed en masse into clean glass beakers containing a 
small amount of home cage bedding to maintain scent.  Pups were held at 34°C and 
50% humidity from 1100 to 1400 hours.  Fresh gloves were rubbed with home cage 
bedding before handling each litter to avoid rejection by the dam.  Corresponding naïve 
mice were born, housed, and weaned during the same time frame to avoid potential 
complications arising from variations in prenatal shipping conditions, housing 
environment, and normal husbandry procedures. All mice were weaned on P22. 
Water avoidance stress 
Water avoidance stress (WAS) was performed for one hour, within the first six 
hours of the light cycle. Mice were placed individually on a round platform (5 cm 
diameter) centrally affixed to the bottom of a container (36 cm length x 31 cm width x 27 
cm height) filled with room temperature tap water up to 1 cm below the top of the 
platform. 
Urinary bladder distension 
Under inhaled isoflurane (4% induction, 2% maintenance), the bare ends of two 
Teflon-coated stainless steel electrode wires (0.003” diameter; Grass Technologies, 
West Warwick, RI) were acutely implanted into the left and right abdominal musculature 
using a 26-gauge needle. A 24-gauge angiocatheter was inserted intravesically via the 
urethra and secured in place with tape.  Anesthesia was lowered until hindlimb reflexes, 
but not escape behaviors, were present (approximately 1% isoflurane).  A custom-made 
distension control device (The University of Iowa Medical Instruments, Iowa City, IA) 
was used to control the gas flow from a compressed nitrogen tank equipped with a dual-
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stage low delivery pressure regulator (Matheson-Linweld, Kansas City, MO) and a 
separate pressure monitor (World Precision Instruments, Sarasota, FL) was used to 
regulate the pressure within the bladder.  Following three 60mmHg distensions to 
establish stable responses, each pressure (15, 30, 45, 60mmHg) was applied in 
triplicate for 20 seconds with a 2-minute rest period in between.  Electromyographic 
(EMG) activity was amplified, filtered, and recorded using Spike 2 software (Cambridge 
Electronic Design, Cambridge, UK) on a personal computer and analyzed off-line.  The 
visceromotor response (VMR) was quantified by measuring the area under the curve of 
the entire distension period divided by the duration of the distension and expressed as a 
percent of baseline activity.   
Colorectal distension 
Electrode implantation was performed as previously described (249). Under 
inhaled isoflurane (4% induction, 2% maintenance) and aseptic conditions, the bare 
ends of two Teflon-coated stainless steel electrode wires (0.003” diameter; Grass 
Technologies) were surgically implanted into the right abdominal musculature, secured 
via 5-0 prolene sutures, tunneled subcutaneously to a small incision made in the nape 
of the neck, and externalized for access during testing.  Skin incisions were closed 
using 5-0 silk suture. Following recovery from anesthesia, mice were housed singly and 
allowed to recover for a minimum of 4 days before undergoing testing.   
To facilitate balloon insertion and maintain proper restraint during testing, mice 
were briefly sedated with inhaled isoflurane and a custom-made polyethylene plastic 
balloon (length, 1.5 cm; diameter, 0.8 cm) was inserted into the distal colon, 0.5cm past 
the anal verge, and secured to the base of the tail with tape. The mouse was then 
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placed into a Broome-style rodent restraint (Kent Scientific, Torrington, CT), the free 
ends of the electrode wires were attached to a differential amplifier (Model 1700, A-M 
Systems, Sequim, WA), and the mice were allowed to recover from anesthesia for 30 
minutes. The balloon was inflated with air from a compressed nitrogen tank equipped 
with a dual-stage low delivery pressure regulator (Matheson-Linweld) and a separate 
pressure monitor (World Precision Instruments) was used to regulate the pressure 
inside the balloon.  Each pressure (15, 30, 45, 60, 75mmHg) was applied in triplicate for 
20 seconds with a 4-minute rest period in between.  A custom-made distension control 
device (The University of Iowa Medical Instruments) was used to control the gas flow 
through the system.  The EMG activity was amplified, filtered, and recorded off-line as 
described for UBD.  
Micturition analysis  
Mice were gavaged with 300µL drinking water and immediately placed on a piece 
of filter paper and covered by a clear plexiglass container (36 cm length x 20 cm width x 
13 cm height) for 1 h.  The number and size of urine spots were measured using Image 
J following visualization with ultraviolet light.  Micturition frequency and total fecal output 
were determined as the total number of individual urine spots or fecal pellets, 
respectively. Total urine output was determined by quantifying the total area of urine 
spots during the testing period.  
Mast cell infiltration and degranulation  
Urinary bladder and distal colon were separately mounted in Tissue-Tek OCT 
mounting media (Sakura Finetek, Torrance, CA) and cut transversely into thin sections 
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(7 µm) using a cryostat.  Slides were stained for 10 minutes with a 1% toluidine blue 
solution acidified with 1M HCl to a pH less than 1.0, dried overnight, washed and 
coverslipped with 1xPBS for analysis.  Using light microscopy (Nikon eclipse 90i, Nikon 
Instruments, Inc., Melville, NY), digital images were captured (QIClick digital CCD 
Camera, QImaging, Surrey, BC, Canada) and the total number of non-degranulated 
(NG) mast cells (dense metachromasia with no or faint nuclear outline and/or no 
granular extrusion around the cell) and degranulated (DG) mast cells (less intense 
metachromasia and obvious clear outline of the nucleus and/or free granules within the 
cytoplasm) were counted in at least 8 separate sections spanning the length of each 
tissue.  The percentage of DG to total mast cells was calculated according to the 
following equation for each tissue/mouse: (DG mast cells/Total mast cells) x 100 
mRNA extraction and qRT-PCR 
Mice were overdosed with inhaled isoflurane (>5%) and, following decapitation, 
whole brains were removed and frozen on dry ice.  Hypothalamus and hippocampus 
were dissected, immediately snap frozen in liquid nitrogen, and stored at -80C. The 
urinary bladder and distal 1.5cm segment of the colon were also removed and 
subsequently bisected longitudinally (to facilitate both mRNA and protein [see below] 
analysis), snap frozen in liquid nitrogen, and stored at -80°C.  Total mRNA was isolated 
using Trizol reagent (Ambion, Austin, TX) and RNeasy micro kit (Quiagen, Valencia, 
CA), as per the manufacturer’s instructions.  Sample concentration and purity was 
determined using a 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA) and 
cDNA was synthesized from total RNA (0.5µg) using the iScript cDNA synthesis kit (Bio-
Rad Laboratories, Hercules, CA).  Quantitative, real-time PCR amplification was 
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performed using 0.2 µg of total cDNA (from the 0.5 µg reverse-transcribed cDNA) and 
SsoAdvanced SYBR Green Supermix (Bio-Rad) on a Bio-Rad CFX manager 3.1 real 
time PCR system with indicated 20µM primers (Integrated DNA Technologies, 
Coralville, IA) listed in Table 3.2.  Samples were run in triplicate and negative control 
reactions were run with each amplification series with β-actin (bladder and colon) or 
GAPDH (brain) as the housekeeping gene.  To reduce variability among efficiency due 
to fluctuations in baseline fluorescence, the raw (i.e. non-baseline corrected) PCR data 
was imported to the LinRegPCR software (version 2012.3) (359-361) and PCR 
efficiency values were derived for each individual sample by fitting a regression line to a 
subset of data points within the sample’s log-linear phase.  Threshold cycle (Ct) values 
were subtracted from that of the selected housekeeping gene and the percentage of 
fold change over naïve controls was calculated using the Pfaffl method (362).   
Protein analysis 
Total protein was isolated using Cell Extraction Buffer containing Halt protease 
and phosphatase inhibitors (ThermoFisher Scientific, Waltham MA) and Na3VO4.  
Protein concentrations were determined using a Dc protein assay (ThermoFisher 
Scientific).  Samples were reduced by heating to 95°C for 5 minutes in the presence of 
2-mercaptoethanol, subjected to SDS-PAGE (Criterion 4% to 12% Bis-Tris gels; Bio-
Rad Laboratories), and transferred to Nitrocellulose transfer membrane (Whatman 
GmbH, Dassel, Germany) by Criterion Blotter wet transfer (Bio-Rad).  The membranes 
were blocked for 1 hour at room temperature in 5% milk in Tris-buffered saline with 
Tween-20 then incubated overnight at 4°C with CRF1 (1:500), CRF2 (1:800), PAR2  
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Table 3.2 Primers used for real-time PCR analysis 
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(1:1000), and TRPA1 (1:1000) antisera.  Membranes were washed with Tris-buffered 
saline with Tween-20 and incubated for 1 hour with anti-rabbit secondary antibody 
(1:10,000).  Densitometry was performed using Quantity One 4.6.9 software (Bio-Rad 
Laboratories).   
Statistics 
Calculations were performed on Microsoft Excel and statistical analysis was 
performed using two-way (with or without repeated measures) analysis of variance 
(ANOVA) followed by Bonferroni’s posttest (GraphPad Prism 6, GraphPad Software, 
Inc, La Jolla, CA) as denoted in the results/figures.  All data are expressed as mean  
SEM. A p value of less than 0.05 was considered significant. 
Vaginal lavage 
The perineum was dried from urine and 100 µl of phosphate buffered saline 
(PBS) was gently expelled into the vaginal canal 3 times with a transfer pipette without 
penetrating the vaginal orifice. The collected fluid was placed into a single well of a 96-
well plate and immediately examined with light microscopy.  The stage of estrous cycle 
was recorded by determining the ratios of the following cell types: nucleated epithelial 
cells, cornified epithelial cells, and leukocytes.   
3.4 Results 
Neonatal and adult stress alter HPA axis output and regulation 
Previous studies in our laboratory have determined that NMS impacts adult 
anxiety-like behaviors and vaginal sensitivity with associated molecular changes in the 
HPA axis and pelvic viscera of female mice (Chapter 2; (150)).  The purpose of the 
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current study was to determine the impact of acute adult stress exposure on 
measurements of HPA axis output and regulation and pelvic organ sensitivity in the 
same model of female NMS mice.    
To determine changes in the output of the HPA axis, resting serum 
corticosterone (CORT) levels were measured in naïve and NMS mice at baseline and 1 
and 8d post-WAS exposure.  At baseline, serum CORT was significantly elevated in 
NMS mice compared to naïve (Figure 3.1A).  Exposure to WAS significantly depressed 
serum CORT in naïve mice only at 1d post-WAS, as it was returned to baseline levels at 
8d post-WAS (Figure 3.1A). Serum CORT was also significantly reduced in NMS mice 
at 1d post-WAS and remained significantly lower than baseline NMS measurements at 
8d post-WAS (Figure 3.1A).   
Real-time PCR was performed to determine if changes in mRNA expression in 
the hypothalamus may be underlying the differential CORT serum levels in naïve and 
NMS mice. The mRNA level of hypothalamic CRF was not significantly different 
between naïve and NMS mice at baseline or following WAS (Figure 3.1B). Likewise, 
levels of CRF1 mRNA were not affected by NMS or WAS (Figure 3.1C). However, WAS 
significantly increased the mRNA levels of CRF2, GR, and MR in the hypothalamus of 
both naïve and NMS mice, particularly at 8d post-WAS (Figure 3.1D-F).  
To determine potential changes in limbic regulation of the HPA axis, mRNA 
levels of the same genes were measured in the hippocampus.  Unlike in the 
hypothalamus, WAS exposure significantly reduced the mRNA level of CRF1, 
particularly at 8d post-WAS in NMS mice (Figure 3.2A). Exposure to WAS significantly 
increased CRF2 mRNA levels in the hippocampus, particularly at 8d post-WAS (Figure  
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Figure 3.1 
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Figure 3.1  To evaluate HPA axis output, serum corticosterone (CORT) and mRNA 
expression of receptors involved in HPA axis regulation in the hypothalamus were 
evaluated in response to neonatal maternal separation (NMS) and water avoidance 
stress (WAS).  A) Serum CORT was significantly elevated in NMS mice compared to 
naïve mice at baseline (BL) and was significantly reduced at 1 and 8d post-WAS 
compared to BL levels. No significant effect of NMS or WAS was observed on 
hypothalamic mRNA levels of corticotropin-releasing factor (CRF, B) or its receptor, 
CRF1 (C).   Exposure to WAS significantly increased mRNA levels of CRF2 (D), 
glucocorticoid receptor (GR, E), and mineralocorticoid receptor (MR, F) in both NMS 
and naïve hypothalamus. Brackets indicate a significant effect of WAS (###, #### p < 
0.001, 0.0001) or NMS/WAS interaction (++ p < 0.01), two-way ANOVA; * p < 0.05 vs. 
naïve; #, ## p < 0.05, 0.01 vs. BL; ‡, ‡‡‡ p <0.05, 0.001 vs. 1d post-WAS; Tukey’s 
posttest. 
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Figure 3.2 
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Figure 3.2  Hippocampal mRNA levels of receptors involved in negative regulation of 
the HPA axis were evaluated in response to neonatal maternal separation (NMS) and 
water avoidance stress (WAS). A) Exposure to WAS significantly decreased the 
hippocampal mRNA level of corticotropin-releasing factor receptor 1 (CRF1) overall, as 
well as in NMS mice at 8d post-WAS compared to baseline (BL) levels. B) NMS 
similarly decreased overall hippocampal mRNA levels of CRF receptor 2 (CRF2), 
however, WAS exposure significantly increased CRF2 mRNA levels in both NMS and 
naïve hippocampus compared to their respective BL and 1d post-WAS levels. C) The 
hippocampal mRNA levels of glucocorticoid (GR) and mineralocorticoid receptor (MR) 
were similarly affected by NMS and an NMS/WAS interaction, resulting in a transient 
decrease in expression at 1d post-WAS in the NMS mice and a return to BL levels at 8d 
post-WAS. E) Despite a slight reduction at 1d post-WAS in NMS mice, no significant 
effects of NMS or WAS were observed on the hippocampal mRNA levels of brain-
derived neurotrophic factor BDNF). Brackets indicate a significant effect of NMS (* p < 
0.05), WAS (#, #### p < 0.05, 0.0001), or NMS/WAS interaction (+ p < 0.05), two-way 
ANOVA; * p < 0.05 vs. naïve; #, ##, ### p < 0.05, 0.01, 0.001 vs. BL; ‡, ‡‡, ‡‡‡ p <0.05, , 
0.01, 0.001 vs. 1d post-WAS; Tukey’s posttest. 
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3.2B); whereas NMS had an overall effect of significantly decreasing hippocampal CRF2 
mRNA levels (Figure 3.2B). Hippocampal GR and MR mRNA levels were significantly 
impacted by NMS and the combined effect of NMS and WAS, resulting in a transient 
decrease in expression in NMS mice at 1d post-WAS and returning to baseline levels at 
8d post-WAS (Figure 3.2C-D).  The mRNA levels of brain-derived neurotrophic factor 
(BDNF) were also measured in hippocampus, however no significant impacts of NMS or 
WAS were observed, despite a trend towards decreased BDNF mRNA at 1d post-WAS 
in NMS mice (Figure 3.2E).  
Neonatal and adult stress exposure impact peripheral cytokine and NGF mRNA 
expression 
Real-time PCR was also used to determine the impact of NMS and WAS on 
peripheral gene expression of cytokines and neurotrophins that are associated with 
dysfunction of the HPA axis (124, 363, 364).  The mRNA level of interleukin-6 (IL6) was 
significantly impacted by a NMS/WAS interaction effect in the bladder (Figure 3.3A) and 
by NMS alone in the colon (Figure 3.3E).  The mRNA level of interleukin-10 (IL10) was 
differentially impacted by NMS and WAS in the two organs, as NMS and WAS both 
significantly increased IL10 expression in the bladder (Figure 3.3B), yet had a significant 
interaction effect on reducing IL10 expression in the colon (Figure 3.3F).  Stem cell 
factor (SCF), a mast cell signaling cytokine and growth factor, was significantly 
increased by WAS in bladder, particularly at the 8d post-WAS time point (Figure 3.3C), 
but no effects of NMS or WAS were observed in colon (Figure 3.3G).  Nerve growth 
factor (NGF) mRNA levels were significantly impacted by WAS and a NMS/WAS 
interaction effect in both bladder (Figure 3.3D) and colon (Figure 3.3H), but with  
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Figure 3.3  The mRNA levels of cytokines and growth factors involved in neurogenic 
inflammation were measured in the bladder (A-D) and colon (E-H) to determine 
alterations in downstream activation of the HPA axis in response to neonatal maternal 
separation (NMS) and water avoidance stress (WAS). A) A significant interaction effect 
of NMS and WAS was observed on mRNA levels of interleukin (IL) 6 in the bladder. 
Both NMS and WAS separately and significantly increased IL-10 mRNA levels in the 
bladder (B), whereas WAS alone or a NMS/WAS interaction significantly increased 
stem cell factor (SCF, C) and nerve growth factor (NGF, D) mRNA levels in the bladder, 
respectively. The mRNA level of IL6 in the colon was significantly increased in NMS 
mice overall (E). A significant NMS/WAS interaction effect was observed for both IL-10 
(F) and NGF (H) mRNA levels in the colon, with NGF mRNA levels being significantly 
elevated at 8d post-WAS in both naïve and NMS colon. The mRNA levels of SCF were 
unaffected by NMS or WAS in the colon. Brackets indicate a significant effect of NMS (*, 
** p < 0.05, 0.01), WAS (#, ##, #### p < 0.05, 0.01, 0.0001), or NMS/WAS interaction (+ 
p < 0.05), two-way ANOVA; # p < 0.05 vs. BL; ‡, ‡‡ p <0.05, 0.01 vs. 1d post-WAS; 
Tukey’s posttest. 
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differential patterns in the NMS mice: WAS significantly increased NGF expression in 
NMS bladder at 8d post-WAS (Figure 3.3D) and transiently decreased expression in 
NMS colon at 1d post-WAS (Figure 3.3H).   
Neonatal and adult stress exposure differentially increase urinary bladder and colorectal 
sensitivity 
The visceromotor response (VMR) during urinary bladder distension (UBD) or 
colorectal distension (CRD) was recorded to evaluate changes in pelvic organ 
sensitivity following WAS in naïve and NMS mice.  In all mice, the VMR during either 
UBD (Figure 3.4A) or CRD (Figure 3.4C) significantly increased in response to greater 
intravesicular or balloon pressure, respectively, confirming a physiological response to 
organ distension (150, 365).  At baseline, the VMR of NMS mice during UBD was 
significantly higher than that of naïve mice over the entire distension series and at the 
highest pressure applied (Figure 3.4A). In contrast, NMS mice displayed significantly 
decreased VMR during CRD, both over the entire distension series and at the highest 
applied pressure (Figure 3.4C). Following exposure to WAS, naïve mice exhibited no 
change in VMR during UBD at either 1d or 8d post-WAS; however, NMS mice displayed 
a transient decrease in VMR during UBD at 1d and a significant increase in VMR at 8d 
post-WAS, when compared to both their 1d post-WAS measurements and their naïve 
counterparts (Figure 3.4B). Exposure to WAS transiently increased VMR during CRD 
only in naïve mice at 1d post-WAS, compared to baseline and NMS VMR (Figure 3.4D).  
The VMR during CRD was unaffected by WAS in NMS mice at both the 1d and 8d time 
points (Figure 3.4D).  No significant correlations between VMR and estrous cycle stage 
were observed in either NMS or naïve mice (data not shown). 
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Figure 3.4  The visceromotor response (VMR) during urinary bladder distension (UBD) 
or colorectal distension (CRD) was measured to determine the impact of neonatal 
maternal separation (NMS) and water avoidance stress (WAS) on pelvic organ 
sensitivity. A) At baseline (BL), NMS mice displayed significantly greater VMR during 
UBD across the entire distension series, and at the highest intravesicular pressure, 
compared to naïve mice.  B) The area under the curve (AUC) was measured for VMR 
during UBD at 1d and 8d post-WAS and compared between NMS and naïve mice. This 
comparison of revealed a significant effect of both NMS and WAS on bladder sensitivity, 
particularly at the 8d post-WAS timepoint when NMS mice displayed an even greater 
increase in bladder sensitivity as compared to naïve mice, which were largely 
unaffected by WAS. C) At BL, NMS mice had a slight, but significant reduction in VMR 
during CRD compared to naïve mice, particularly at the highest intraballoon pressure 
applied. D) The AUC was measured for VMR during CRD at 1d and 8d post-WAS and 
revealed a significant effect of both NMS and WAS on colorectal sensitivity, particularly 
at the 1d post-WAS timepoint when naïve mice had a significant increase in VMR that 
was not observed in NMS mice. Brackets indicate a significant effect of NMS (*, ** p < 
0.05, 0.01) or WAS (#, ## p < 0.05, 0.01), two-way RM ANOVA; * p < 0.05 vs. naïve, 
Bonferroni posttest. 
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Neonatal and adult stress exposure significantly impact urinary bladder output 
The functional output of the bladder and colon was characterized in NMS and 
naïve mice prior-to and following WAS to determine the impact of early life and adult 
stress on micturition and defecation rates.  The number of voidances and total urine 
output were not different between naïve and NMS mice at baseline (Figure 3.5A-B).  
However, at 1d post-WAS, both the number of voidances and total urine output were 
significantly increased in NMS mice, compared to naïve (Figure 3.5A-B). Fecal output 
was also measured pre- and post-WAS and neither NMS nor WAS had a significant 
impact (Figure 3.5C). No significant correlations between urine output or voidance 
frequency and estrous cycle stage were observed in either NMS or naïve mice (data not 
shown). 
Neonatal and adult stress exposure significantly increase mast cell degranulation and 
protein expression of associated pain-signaling receptors in the bladder 
To determine if mast cell activation could be contributing towards the bladder-
specific effects observed in NMS mice following WAS, bladder tissue from NMS and 
naïve mice was processed for mast cell visualization and Western blotting.  Mast cells 
were visualized using acidified toluidine blue and analyzed for state of degranulation 
(Figure 3.6B-C’).  Bladders from NMS mice contained a significantly larger percentage 
of mast cells exhibiting evidence of degranulation than did bladders from naïve mice 
(Figure 3.6A).  Exposure to WAS had an overall effect of increasing mast cell 
degranulation, primarily driven by a non-significant increase in the percentage of 
degranulated mast cells in naïve bladder (Figure 3.6A). Protein expression of the 
tryptase receptor, protease antigen receptor type 2 (PAR2), and transient receptor  
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Figure 3.5  Micturition frequency and output, and fecal output, were measured over a 1 
h testing period to determine changes in bladder or gastrointestinal function resulting 
from neonatal maternal separation (NMS) and water avoidance stress (WAS).  A) Void 
frequency, measured s the number of voidance events during a 1 h test period, was 
significantly increased by NMS. B) WAS significantly increased total urine output during 
the 1 h test period, particularly in NMS mice which had a significantly higher output than 
naïve mice at the 1d post-WAS time point. C) Neither NMS nor WAS significantly 
impacted fecal output. Brackets indicate a significant effect of NMS (*p < 0.05) or WAS 
(# p < 0.05), two-way RM ANOVA; * p < 0.05 vs. naïve, Bonferroni posttest. 
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Figure 3.6  
 
 
 
 
 
 
 
101 
 
Figure 3.6  The extent of mast cell degranulation and the protein levels of the tryptase 
receptor, protease-activated receptor 2 (PAR2) and the transient receptor potential 
ankyrin 1 (TRPA1) were measured in the bladder to determine the potential role of the 
mast cell-nerve axis in bladder hypersensitivity resulting from neonatal maternal 
separation (NMS) and water avoidance stress (WAS). Intact (red arrow, B, B’) and 
degranulated (red arrowhead, C, C’) mast cells were visualized in bladders from NMS 
and naïve mice at baseline (BL) and 1d post-WAS. A significant effect of NMS and WAS 
was observed on mast cell degranulation, such that NMS bladder had a significantly 
larger percentage of degranulated mast cells, both at BL and 1d post-WAS (A). WAS 
significantly increased protein levels of both PAR2 (D) and TRPA1 (E) in the bladder 
from naïve and NMS mice.  Representative Western blots are shown for PAR2, TRPA1, 
and corresponding GAPDH protein expression with bands at 32, 127, and 35kD, 
respectively. Brackets indicate a significant effect of NMS (**** p < 0.0001) or WAS (#p 
< 0.05), two-way ANOVA; *, ** p < 0.05, 0.01 vs. naïve, Tukey’s posttest. Scale bars 
represent 100µm (B, C) and 10µm (B’, C’). 
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potential ankyrin repeat 1 (TRPA1) was significantly increased following WAS exposure 
in both naïve and NMS bladder (Figure 3.6F-G).  
3.5 Discussion  
Patients suffering from chronic pelvic pain syndromes commonly report symptom 
onset or worsening during times of stress. Experiencing stress or trauma early in life 
increases the likelihood of developing chronic pelvic pain later in life, as well as 
comorbid mood disorders (281).  Here we have provided the first evidence of early life 
stress-induced bladder hypersensitivity in mice.  Exposure to adult stress further 
exacerbated urinary bladder sensitivity in NMS mice and, conversely increased 
colorectal sensitivity in naïve mice.  Together with enhanced neuroimmune profiles in 
the bladder and molecular evidence of diminished HPA axis regulation, these data 
suggest that NMS alters the response to stress later in life. 
In our previous study, we demonstrated that performing NMS throughout the 3 
week pre-weaning period resulted in a stronger phenotype than the standard 14 day-
long separation period, which we attributed to disruption of proper limbic structure 
maturation during the third week of life (150).  Here, we show that although WAS-
induced changes in mRNA levels were observed in both the hypothalamus and 
hippocampus, only in the latter were NMS-associated changes denoted.  Exposure to 
WAS significantly, and selectively, decreased the mRNA levels of MR and GR only in 
the NMS hippocampus at the 1d time point and had a longer-lasting effect on CRF1 and 
CRF2 mRNA levels. This is opposite what has previously been reported in rat NMS 
models following acute stress exposure, however, this is likely due to variations in NMS-
duration, species, and the nature of the acute stressor (287).  The transient decrease in 
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mRNA levels returned to naïve-like levels by 8d post-WAS, suggesting that negative 
regulation from the NMS hippocampus was acutely, but not chronically, impaired 
following WAS exposure.  Interestingly, WAS-induced changes in mRNA levels in the 
hypothalamus did not differ between naïve and NMS mice, and also were not observed 
until the 8d post-WAS time point.  The observed increase of genes involved in negative 
regulation of the HPA axis, including CRF2, GR, and MR, and the delayed increase in 
expression together suggest that changes in gene expression within the hypothalamus 
may have been driven by the transiently reduced negative regulation from the 
hippocampus.  
Under normal conditions, acute stress exposure induces long term potentiation 
(LTP) in the hippocampus, which underlies learning and memory formation and is 
dependent upon BDNF (366, 367).  Exposure to chronic stress disrupts LTP, which can 
be rapidly reversed by GR antagonist treatment (368).  Exposure to acute or chronic 
stress has been shown to significantly downregulate BDNF mRNA and protein levels in 
the rodent hippocampus, as has treatment with exogenous glucocorticoids (366).  
Dexamethasone treatment or genetic overexpression of GR has been shown to 
increase hippocampal BDNF mRNA or protein levels and, conversely, knockdown of 
GR decreased BDNF protein content in the hippocampus (369, 370).  Our observation 
of a concurrent decrease in hippocampal GR and BDNF mRNA levels only in the NMS 
mice at 1d post-WAS, further suggests that the hippocampal response to adult stress is 
dysregulated following neonatal stress exposure.    
Despite no transcriptional evidence of decreased regulation of the HPA axis at 
baseline, we observed an increase in resting serum CORT concentration in NMS mice 
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prior to WAS exposure.  Following exposure to WAS, serum CORT levels from NMS 
mice remained lower than those from naïve mice, further suggesting a maladaptive 
response to adult stress.  Genetic deletion of CRF2 has been shown to increase basal 
and evoked CORT levels, without affecting the mRNA level of CRF in the hypothalamus 
(86).  Therefore, the observed changes in serum CORT levels in the current study could 
be driven, in part, by the significant and robust increase in CRF2 mRNA level in both the 
hypothalamus and hippocampus.  The mechanisms underlying the specific increase in 
CRF2, and the significance thereof, will be a focus of future investigation.   
Increased colorectal (146, 319, 344, 355) or vaginal (150) hypersensitivity has 
previously been shown to manifest in rodent models of NMS and this study provides the 
first evidence of urinary bladder hypersensitivity following NMS in female mice.  
Baseline bladder hypersensitivity was further exacerbated by exposure to WAS, in a 
delayed and prolonged fashion, but this increase in urinary bladder hypersensitivity was 
observed only in the NMS mice and a more immediate increase in colorectal sensitivity 
was observed only in naïve mice.  The difference in VMR at 1d post-WAS, both in terms 
of NMS- and organ-effect, likely reflects a dysregulated stress-response in NMS mice 
rather than stress-induced hypoalgesia, considering that naïve mice showed no change 
in VMR during UBD and an increase in VMR during CRD at the same time point.  
Likewise, the gene expression changes in the hippocampus of NMS mice at 1d post-
WAS point towards decreased regulatory input.  Interestingly, the current study revealed 
an overall negative impact of NMS on colorectal sensitivity, both at baseline and 
following WAS, which is contradictory to previous studies using a 14d-long NMS 
protocol in either rats (146, 287, 371) or mice (319) and suggests that a three-week long 
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NMS protocol in mice may generate a phenotype restricted to the urogenital organs 
(150).  
Subsets of IC/PBS patients that report histories of early life stress such as sexual 
and physical abuse frequently present with increased voiding and urgency (18, 284, 
372), and individuals that experienced multiple types of maltreatment are more likely to 
develop comorbid pain disorders (373).  Furthermore, patients with bladder dysfunction, 
in the absence of pain, are more likely to report early life abuse than the general 
population (374).  Increased expression of CRF and CRF2 was observed in both the 
urothelium and associated innervation of the bladder following cyclophosphamide-
induced bladder inflammation in rats (375), and micturition retention has been reported 
in mice exposed to social defeat stress (376, 377).  Single or chronic WAS exposure 
has been shown to increase micturition rates in female (153) and male (378) rats, but 
with sex-dichotomous outcomes resulting in decreased and increased void volumes, 
respectively.  In the present study, female NMS mice exhibited increased micturition 
rate while WAS exposure significantly increased average urine output for each voidance 
event in this group.  Strikingly, neither NMS nor WAS had effects on fecal output, 
increased rates of which have been reported in animal models of IBS in males, a 
phenotype sensitive to CRF antagonism (379-382).  Here, we report altered micturition, 
but not defecation, following WAS in NMS females that parallels the heightened 
urogenital sensitivity in mice that underwent early life stress. 
The role of mast cells in driving neurogenic inflammation and visceral afferent 
sensitization in mucosal diseases such as IBS and asthma is well recognized (105, 
106).  Degranulated mediators from mast cells, including tryptase and histamine, bind to 
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protease activated receptors (PAR) on nearby visceral afferents and can drive stress-
mediated sensitization, a process thought to contribute to chronic functional pain (124, 
125). Increased tryptase, histamine, IL6, and nerve growth factor (NGF) have all been 
reported in the urine of IC/PBS patients (383).  This nerve-mast cell axis is perpetuated 
by the chemoattraction of mast cells to antidromic release of peptidergic molecules 
(127, 128), which, in turn, has been shown to increase mast cell cytokine expression 
(129).  Here we observed a significant increase in mast cell degranulation in NMS 
bladder compared to naïve.  Although both naïve and NMS mice had similar increases 
in the mRNA levels of the mast cell signaling cytokine, SCF, and both IL6 and NGF 
were specifically increased in NMS bladder at 8d post-WAS indicating greater 
neuroimmune activation in this tissue.  Indeed, mast cell activation and associated 
pelvic organ hypersensitivity has been shown to be increased by acute stress, a 
phenotype that can be prevented, but not reversed, by treatment with mast-cell 
stabilizers (116, 384).   
Physiological stress signaling within the viscera results in phenotypes suggesting 
heightened neuro-immune interactions underlying visceral hypersensitivity in animal 
models of IBS (146-149), vulvodynia (150), and IC/PBS (144, 151-153).  On one hand, 
CRF1 has been implicated in WAS-induced colorectal hypersensitivity (385) and gut-
barrier dysfunction (318, 386); however, CRF2 antagonism blocked the release of the 
proinflammatory cytokine IL6 from cultured cardiomyocytes (387) and expression of 
IL10 was increased in cytotrophoblast cells by a CRF2-mediated mechanism (388).  
Similarly, stress-induced bladder hypersensitivity and vascular permeability have also 
been shown to be driven by a CRF2 rather than a CRF1-mediated mechanism (144, 
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145).  Here, we report expression of IL6 and IL10 were increased by NMS and 
enhanced by WAS in bladder.  Interestingly, mast cells, rather than T-regulatory cells or 
macrophages are the major source of IL10 in the bladder (389). 
Neonatal stress or visceral injury has been shown to alter expression of 
inflammatory mediators and TRP channels in the pelvic viscera, changes implicated in 
driving chronic pain phenotypes (126, 139, 142, 147, 149, 300, 386).  Bladder sensitivity 
and urination frequency during hemorrhagic cystitis or spinal cord injury has been 
shown to be mediated by a TRPA1 mechanism (390, 391).  TRPA1 and TRPV1 have 
been shown to be sensitized in vivo by stimulation of PAR receptors from factors such 
as those released from degranulated mast cells (139, 142) and likely contributes to 
chronic functional pain (124, 125).  Furthermore, early life stress increased TRPA1 
protein expression in bladder (150) while experimental cystitis induced a TRPA1-, but 
not TRPV1-dependent hyperalgesia (392).  Expression of mast cell mediators such as 
histamine and NGF as well as the tryptase receptor are susceptible to stress-induced 
increases in the bladder (393) that are not observed in mast cell deficient rats (394).  
Here, we report acute stress increased expression of PAR2 and TRPA1 in the bladder, 
findings that when combined with the increased activation of mast cells in the bladder, 
indicate a heightened presence of neuroimmune signaling in NMS mice.  Indeed, 
bladder, but not colon, NGF was upregulated in NMS, but not naïve, mice exposed to 
WAS.   
3.6 Conclusion 
 This study provides evidence that early life stress in female mice increased 
susceptibility to stressful events in adulthood.  Altered gene expression in the 
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hypothalamus following WAS exposure, which was precipitated by hippocampal gene 
changes, suggests that NMS disrupts negative limbic regulation of the HPA axis. This 
manifested behaviorally in NMS mice as increased bladder sensitivity both at baseline 
and 8d after WAS exposure, as well as increased functional output from the bladder.  
Peripheral evidence of neurogenic inflammation in the bladder, including increased 
mast cell degranulation and pro-inflammatory gene expression, suggest increased 
downstream activation of the HPA axis may drive the specific urological hypersensitivity. 
Together with previous studies demonstrating psychological abnormalities and pelvic 
organ sensitivities associated with NMS, this study provides new insight into 
mechanisms that contribute to stress-associated symptom onset and exacerbation in a 
population of patients exposed to early life stress.   
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Chapter 4 
 
Voluntary exercise can prevent or reverse urinary bladder hypersensitivity and 
dysfunction in maternally-separated female mice 
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4.1 Abstract 
 Urogenital pain patients commonly report having experienced adverse events 
early in life, which has been shown to disrupt proper functioning of hypothalamic-
pituitary-adrenal (HPA) axis, thereby permanently altering stress responses and the 
perception of pain.  Voluntary exercise has been shown to attenuate many of the 
negative outcomes associated with HPA axis dysfunction; however, the therapeutic 
potential of exercise for improving urogenital pain and dysfunction or comorbid mood 
disorders arising from early life stress has not been determined.  Therefore, we housed 
female mice, that did (NMS) or did not (naïve) undergo daily maternal separation from 
postnatal day 1-21, in cages with free access to running wheels beginning at 4 or 8 
weeks of age to determine if exercise could prevent or reverse urogenital 
hypersensitivity and dysfunction or altered patterns of sucrose intake resulting from 
early life stress. Sedentary NMS mice displayed significantly increased visceromotor 
response (VMR) during urinary bladder distension (UBD), had an increased micturition 
rate, and consumed greater volumes of sucrose compared to sedentary naïve mice.  
Exercise beginning at 4 or 8 weeks of age significantly diminished VMR, improved 
micturition events, and further enhanced sucrose intake in NMS mice. Exercise also 
prevented or reversed the increase in mast cell degranulation and expression of the 
tryptase receptor, PAR2, in NMS bladder. In the hippocampus, a limbic regulator of the 
HPA axis, exercise increased expression of brain-derived neurotrophic factor while 
glucocorticoid receptor remained elevated in NMS.  Taken together, these findings 
provide novel insight on the efficacy of exercise, an easily translatable clinical 
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intervention, as a potential treatment strategy for chronic urogenital hypersensitivity and 
neuroimmune dysfunction associated with early life stress. 
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4.2 Introduction 
Voluntary physical activity and exercise training exerts a wide range of metabolic, 
neuroendocrine, and neurobiological effects.  While exercise physiology has been 
studied for many decades, the full potential of health benefits derived from exercise 
have not been explored.  Specifically, no studies have evaluated the impact of exercise 
on animal models of stress-induced chronic pelvic pain (CPP).  Interstitial cystitis/painful 
bladder syndrome (IC/PBS) is characterized by chronic pain and urologic dysfunction 
and associated with altered activity of the hypothalamic-pituitary-adrenal (HPA) axis, 
which is thought to contribute to comorbid mood disorders (57, 227, 265, 395) and 
neuroendocrine dysfunction within the viscera (353, 372).  The hippocampus in 
particular is a source of neural circuitry that provides negative feedback onto the HPA 
axis, which is mediated, in part, through the glucocorticoid receptor (GR) (65, 396).  
Peripherally, mast cells may become partially or fully degranulated in response to a 
range of stimuli, including glucocorticoids (397).  Tryptase, a major inflammatory 
mediator released by activated mast cells, binds to and activates the protease activated 
receptor (PAR) 2, which has been shown to sensitize transient receptor channels 
vanilloid 1 and ankyrin 1 (TRPV1 and TRPA1) in vivo (139, 142), receptors required for 
the transmission of noxious inflammatory stimuli (134, 137).   
Under normal conditions, exposure to acute stress enhances learning and 
memory formation via brain-derived neurotrophic factor (BDNF)-induced long-term 
potentiation (LTP) of hippocampal neurons, a process that is mediated by 
glucocorticoids (366) and is critical for adaptation to stress (398).  Chronic stress, on the 
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other hand, diminishes LTP, decreases neurogenesis, and disrupts crosstalk between 
GR and the BDNF receptor, tyrosine receptor kinase (Trk)-B, in the hippocampus (72, 
368, 399).  Administration of exogenous glucocorticoids or dexamethasone challenge 
has also been shown to diminish BDNF expression and LTP (367); however, neuronal 
activity secondary to exercise or cognitive challenges can upregulate BDNF expression 
and associated neurogenesis in the hippocampus (222, 223).  Through the interactions 
of BDNF on its cognate receptor, TrkB with N-methyl-d-Aspartate receptors (NMDAR) 
and GR, potentiation of glutamatergic input to inhibitory interneurons in the 
hypothalamus likely influences negative feedback upon the HPA axis (72, 224, 400).   
For several decades, neonatal maternal separation (NMS) has been used as a 
rodent model of early life stress (401-405) and has been shown to confer long-term 
changes in limbic, reward, and stress circuitry in central brain regions (150, 406, 407) 
that are also heavily influenced by exercise (225).  In fact, voluntary exercise has been 
shown to normalize hippocampal BDNF and GR gene expression in NMS rats, as well 
as concordant behavioral responses to acute stress exposure (272).  While exercise 
intervention has been shown to ameliorate some of the negative effects of NMS (272, 
406), no study has evaluated the impact of exercise on stress-associated visceral 
hypersensitivity.  Therefore, pairing exercise as an intervention for the negative effects 
of NMS is not only warranted but also translatable to clinical practice.  This project 
tested the potential for exercise to ameliorate the predominant behavioral changes in 
female mice following NMS, namely urological hypersensitivity and altered micturition 
behavior.  Broadening the impact of our findings, this project also evaluated behaviors 
indicative of conditions comorbid with IC/PBS, including mood and somatic pain 
114 
 
disorders, and the potential impact exercise has on these comorbidities.  Finally, 
molecular and cellular changes downstream of neuroendocrine dysfunction were 
investigated, specifically, expression of GR and BDNF in the hippocampus and mast 
cell degranulation and PAR2 expression in the bladder and whether these factors were 
responsive to exercise intervention. 
4.3 Materials and methods 
Neonatal maternal separation 
Litters were born in house from pregnant dams (Charles River, Wilmington, MA) 
delivered to the laboratory animal facility during the last week of gestation.  Day of birth 
was designated as postnatal day (P) 0 and on P1 through P21 individual litters were 
removed daily and placed en masse into clean glass beakers containing a small amount 
of home cage bedding to maintain scent.  Pups were held at 34°C and 50% humidity 
throughout the separation time period (generally from 1100 - 1400 hours).  The 
investigator’s gloves were changed between litters and fresh gloves were rubbed with 
home cage bedding before handling.  Corresponding naïve mice were born, housed, 
and weaned during the same time frame as NMS mice to avoid potential complications 
arising from variations in prenatal shipping conditions, housing environment, and normal 
husbandry procedures.   All mice were weaned on P22.  
Exercise 
For the early exercise group, four week-old NMS and naïve animals were pair-
housed with littermates to minimize the potential effects of social isolation in cages 
equipped with ad libitum access to a stainless steel running wheel for the duration of the 
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study (Mini Mitter; Bend, OR).  Corresponding sedentary NMS and naïve animals 
remained housed with littermates in standard cages compliant with IACUC enrichment 
standards.  For the late exercise group, baseline behaviors were first established in 
eight week-old NMS and naïve animals and the mice were then singly-housed in cages 
equipped with free access to running wheels.  Quantification of wheel revolutions was 
monitored by Vital View Acquisition and Analysis software (Harvard Apparatus, 
Holliston, MA) and average running distance per week per animal (late exercise) or per 
pair of animals (early exercise) was calculated on a personal computer off-line. 
Vaginal lavage  
The vaginal opening was rinsed of urine and 100 µl of phosphate buffered saline 
(PBS) was gently expelled into the vaginal canal 3 times with a transfer pipette.  Care 
was taken to not penetrate the orifice. The collected fluid was placed into a single well 
of a 96-well plate and immediately examined with light microscopy.  The stage of 
estrous cycle was recorded by determining the ratios of the following cell types: 
nucleated epithelial cells, cornified epithelial cells, and leukocytes.   
Urinary bladder distension 
Under inhaled isoflurane (4% induction, 2% maintenance), the bare ends of two 
Teflon coated electrodes (0.003” diameter; Grass Technologies, West Warwick, RI) 
were acutely implanted into the right and left abdominal musculature using a 26-gauge 
needle and a 24-gauge angiocatheter was inserted intravesically via the urethra and 
secured via tape.  Following catheterization, isoflurane anesthesia was lowered until 
hindlimb reflexes, but not escape behaviors, were present (approximately 0.9% 
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isoflurane).  A custom-made distension control device (The University of Iowa Medical 
Instruments, Iowa City, IA) was used to control the gas flow from a compressed nitrogen 
tank equipped with a dual-stage low delivery pressure regulator (Matheson-Linweld, 
Kansas City, MO) and a separate pressure monitor (World Precision Instruments, 
Sarasota, FL) was used to regulate the pressure within the bladder.  Following three 
60mmHg distensions to establish stable responses, each pressure (15, 30, 45, 
60mmHg) was applied in triplicate for 20 seconds with a 2-minute rest period in 
between. Electromyographic (EMG) activity was amplified, filtered, and recorded using 
Spike 2 software (Cambridge Electronic Design, Cambridge, UK) on a personal 
computer and analyzed off-line.  The visceromotor response (VMR) was quantified by 
measuring the area under the curve of the entire distension period and expressed as a 
percent of baseline activity. Immediately following UBD, animals were monitored for 
estrous cycle stage and returned to their home cages. 
Micturition events 
Animals were placed on a piece of filter paper and covered by a clear plexiglass 
container (36 cm length x 20 cm width x 13 cm height) for 1 h duration.  The number 
and size of urine spots were measured using Image J following visualization with 
ultraviolet light (408).  Micturition frequency, average urine output for each micturition 
event, and total fecal output were analyzed across all groups.  All testing took place 
during the early portion of the light-cycle (before 0900 h) to control for effects of diurnal 
rhythms of stress hormones.  After the testing procedure, animals were monitored for 
estrous cycle stage and returned to their home cages.   
Sucrose preference placement 
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 Mice were individually housed in BioDAQ Liquid Choice Unplugged Allentown 
cages (Biological Data Acquisition, New Brunswick, NJ) equipped with two Polysulfone 
BioDAQ drinking bottles.  Following a two-day acclimatization period during which both 
bottles contained standard drinking water, one bottle was filled with 1% sucrose diluted 
in drinking water and fluid volume levels were recorded and the position of the bottles 
interchanged daily for a total of two days.  The total volume of 1% sucrose consumed, 
as well as the percentage of 1% sucrose was calculated. 
Mast cell degranulation  
Prior to sacrifice, vaginal lavage and cytology was performed daily, for at least 4 
consecutive days, to determine cycle stage.  Upon verification of estrus, mice were 
transcardially perfused with ice cold 4% paraformaldehyde and whole bladder tissue 
and dura mater from the supratentorial calvaria were removed, postfixed for 1 hour, and 
cryoprotected overnight in 30% sucrose at 4C.  Bladders were washed in 1x PBS and 
flash frozen in ice cold heptane.  Bladder cryosections were cut at 10 µm thickness from 
whole tissue mounted in Tissue-Tek OTC mounting medium (Sakura Finetek, Torrance, 
CA) using a cryostat.  The dura mater was washed in 1x PBS and whole-mounted onto 
slides and stored at -20°C until staining.  Non-serial sections spanning the length of 
bladder tissue and whole-mounted dura mater were stained with a 1% toluidine blue 
solution acidified with 1M HCl to a pH less than 1.0, dried overnight, dehydrated with 
95% and 100% ethanol-dips, and coverslipped with 1x PBS for analysis.  Using light 
microscopy (Nikon eclipse 90i, Nikon Instruments, Inc., Melville, NY), digital images 
were captured (QIClick digital CCD Camera, QImaging, Surrey, BC, Canada) and the 
total number of non-degranulated (NG) mast cells (dense metachromasia with no or 
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faint nuclear outline and/or no granular extrusion around the cell) and degranulated 
(DG) mast cells (less intense metachromasia and obvious clear outline of the nucleus 
and/or free granules within the cytoplasm) were counted in at least 8 separate sections 
spanning the length of bladder tissue or 10 non-adjacent fields (800 µm2 per field) 
across the dura mater.  The percentage of DG to total mast cells was calculated for 
each tissue/mouse and differences between groups were analyzed. 
mRNA extraction and qRT-PCR 
 Vaginal lavage and cytology was performed daily, for at least 4 consecutive days, 
to determine cycle stage.  Upon verification of estrus (approximately 1 week after UBD) 
mice were deeply anesthetized with inhaled isoflurane (>5%) and, following 
decapitation, whole brains were removed and frozen on dry ice.  Bilateral hippocampi 
were dissected, immediately snap-frozen in liquid nitrogen, and stored at -80°C.  The 
urinary bladder was removed and bisected longitudinally for both mRNA and protein 
(see below) analysis, snap-frozen in liquid nitrogen, and stored at -80°C until 
processing.  Total mRNA was isolated using Trizol reagent (Ambion, Austin, TX) and 
RNeasy micro kit (Quiagen, Valencia, CA) as per manufacturer’s instructions.  Sample 
concentration and purity was determined using a 2100 bioanalyzer (Agilent 
Technologies, Santa Clara, CA) and cDNA was synthesized from total RNA (0.5 µg) 
using the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA).  Quantitative 
real-time PCR amplification was performed using 0.2 µg of total cDNA (from the 0.5 µg 
reverse-transcribed cDNA) and SsoAdvanced SYBR Green Supermix (Bio-Rad) on a 
Bio-Rad CFX manager 3.1 real time PCR system with indicated 20 µM primers 
(Integrated DNA Technologies, Coralville, IA) as listed in Table 4.1.  Samples were run  
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Table 4.1 Primers used for real-time PCR analysis 
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in triplicate and negative control reactions were run with each amplification series with 
β-actin (bladder) or GAPDH (hippocampus) as the housekeeping gene.  To reduce 
variability among efficiency due to fluctuations in baseline fluorescence, the raw (i.e. 
non-baseline corrected) PCR data was imported to the LinRegPCR software (version 
2012.3) (359-361) and PCR efficiency values were derived for each individual sample 
by fitting a regression line to a subset of data points within the sample’s log-linear 
phase.  Threshold cycle (Ct) values were subtracted from that of the selected 
housekeeping gene and the percentage of fold change over naïve controls was 
calculated using the Pfaffl method (362). 
Protein analysis 
Upon confirmation of estrus, mice were overdosed with inhaled isoflurate (>5%) 
and, following decapitation, dura mater from the supratentorial calvarium was dissected 
and flash frozen in liquid nitrogen while the urinary bladder was longitudinally bisected 
(as mentioned above) and flash frozen in liquid nitrogen.  Total protein was isolated 
using Cell Extraction Buffer containing Halt protease and phosphatase inhibitors 
(ThermoFisher Scientific, Waltham MA) and Na3VO4.  Protein concentrations were 
determined using a Dc protein assay (ThermoFisher Scientific, Waltham, MA).  Samples 
were reduced by heating to 95°C for 5 minutes in the presence of 2-mercaptoethanol, 
subjected to SDS-PAGE (Criterion 4% to 12% Bis-Tris gels; Bio-Rad Laboratories), and 
transferred to Nitrocellulose transfer membrane (Whatman GmbH, Dassel, Germany) by 
Criterion Blotter wet transfer (Bio-Rad).  The membranes were blocked for 1 hour at 
room temperature in 5% milk in Tris-buffered saline with Tween-20 then incubated 
overnight at 4°C with antisera to PAR-2 (1:500; Abcam, Cambridge, MA) and GAPDH 
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(1:1000; Cell Signaling Technology, Beverly, MA).  Membranes were washed with Tris-
buffered saline with Tween-20 and incubated for 1 hour with anti-rabbit secondary 
antibody (1:10,000; Cell Signaling Technology, Beverly, MA).  Densitometry was 
performed using Quantity One 4.6.9 software (Bio-Rad Laboratories). 
Age of mice at experimental time points 
Within the early and late exercise paradigms, separate cohorts of mice were 
used for behavioral tests: UBD, micturition, SPP, and forepaw sensitivity at the indicated 
ages (Table 4.2).  Approximately 1 week post-UBD, animals were euthanized for tissue 
collection to be used in mast cell degranulation assay, western blotting, or qRT-PCR as 
described above.  Multiple cohorts were chosen because behavioral testing might be 
considered an acutely stressful experience, which has been shown to alter expression 
of inflammatory mediators in the pelvic organs and the genes involved in the regulation 
of the HPA axis in the hippocampus (150). 
Statistical analysis 
Calculations were performed on Microsoft Excel and statistical analysis was 
performed using 2-way (with or without repeated measures) analysis of variance 
(ANOVA) followed by Bonferroni’s or Tukey’s posttest (GraphPad Prism 6, GraphPad 
Software, Inc, La Jolla, CA) as denoted in the results section. All data are expressed as 
mean  SEM. A p value of less than 0.05 was considered significant. 
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Table 4.2 Age of mice at experimental time points. 
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Table 4.2  NMS and corresponding naïve mice underwent behavioral testing at the 
above noted ages (in weeks).  Mice that underwent early exercise were housed in 
cages with free access to running wheels from 4-8 weeks of age.  At 8 weeks of age, 
individual cohorts underwent urinary bladder distension (UBD), micturition analysis, two-
choice sucrose preference test, or mechanical forepaw sensitivity testing.  Mice in the 
late exercise group underwent baseline UBD testing at 8 weeks of age, and afterward, 
were immediately housed in cages with free access to running wheels until 12 weeks of 
age at which point UBD was retested.  Tissue for mRNA, protein, and mast cell analysis 
was utilized from naïve and NMS mice 1 week following UBD: 9 weeks of age in early 
exercise mice (mast cells only) and 13 weeks of age in late exercise mice. 
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4.4 Results 
Exercise ameliorates bladder hypersensitivity and dysfunction in NMS mice 
To determine whether voluntary exercise could modify bladder hypersensitivity 
and over-activity resulting from NMS, mice were housed with free access to running 
wheels beginning at either 4 (early exercise) or 8 (late exercise) weeks of age.  Mice 
given access to running wheels (-Ex group) were compared to sedentary (-Sed) 
counterparts in the early exercise experiment and to their baseline measurements (-BL) 
in the late exercise experiment to determine if exercise could prevent or reverse NMS-
induced changes, respectively.  The VMR was measured during UBD to determine 
bladder sensitivity and all groups exhibited a significant effect of intravesicular pressure, 
indicating a physiological response to UBD (Figure 4.1).  In both experiments, sedentary 
NMS mice at 8 weeks of age (NMS-Sed and NMS-BL) exhibited a significantly greater 
VMR over the entire distension series, compared to corresponding sedentary naïve 
mice (naïve-Sed and naïve-BL, respectively) (Figure 4.1).  NMS mice that were given 
exercise wheels at 4 weeks (Figure 4.1A) or 8 weeks (Figure 4.1B) of age displayed 
significantly reduced VMR compared to either NMS-Sed or NMS-BL mice, respectively, 
and were not significantly different than their exercised naïve counterparts.  Exercise 
had no significant impact on bladder sensitivity in naïve mice. 
Changes in micturition frequency or habit are commonly observed symptoms in 
IC/PBS (409).  Therefore, we evaluated the impact of NMS and exercise on void 
frequency during a 1 h testing period.  The number of void events was significantly 
increased in NMS-Sed mice compared to naïve-Sed mice (Figure 4.2).  However, 
micturition frequency was not significantly different between NMS and naïve mice given  
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Figure 4.1 
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Figure 4.1  The visceromotor response (VMR) during urinary bladder distension (UBD) 
was measured to determine the effect of early (A) or late (B) exercise intervention on 
neonatal maternal separation (NMS)-induced bladder hypersensitivity. A) Sedentary (-
Sed) NMS mice displayed significant urinary bladder hypersensitivity over the entire 
distension series, compared to naïve-sed mice (p=0.0053). Exercised (-Ex) NMS mice 
that were given running wheels at 4 weeks of age displayed a significantly reduced 
VMR compared to NMS-Sed (p=0.0064). B) Similar to the early exercise group, at 
baseline, NMS mice displayed significantly greater VMR than naïve mice (p=0.0062). 
Following 4 weeks of exercise, the same group of NMS mice displayed a significantly 
reduced VMR compared to their baseline measurements (p=0.0048). Two-way RM 
ANOVA; *,**,*** p<0.05, 0.01, 0.001 vs. naïve-sed (A) or naïve-baseline (BL; B); 
##
, 
### 
p<0.01, 0.001 vs. NMS-Ex; Bonferroni posttest. 
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Figure 4.2  
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Figure 4.2  Micturition frequency was measured over a 1 h test period to determine 
changes in bladder function due to neonatal maternal separation (NMS) or exercise. 
Void frequency, measured as the number of voiding events during a 1 h test period, was 
significantly increased in female sedentary NMS mice compared to sedentary naïve 
mice.  This difference was not observed between NMS and naïve mice given running 
wheels at 4 weeks of age. p=0.0092, two-way ANOVA;  **p<0.01 vs. naïve, Bonferroni 
posttest. 
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running wheels at 4 weeks of age (Figure 4.2).  Exercise had no impact on micturition 
frequency in naïve mice. 
Exercise stabilizes mast cell infiltrates in NMS bladder 
Many studies report evidence of increased mast cell activity in the bladder of 
IC/PBS patients (410-413).  Mast cells are also acutely responsive to stress and both 
secrete- and respond to- stress ligands, such as corticotropin-releasing factor (CRF) 
(120).  Therefore, we quantified the percentage of degranulated to total mast cells in the 
bladder of NMS and naïve mice with or without access to running wheels.   In both 
groups of mice, sedentary NMS mice at 8 weeks of age exhibited a significant increase 
in mast cell degranulation, compared to sedentary naïve counterparts (Figure 4.3).  
Exercise beginning at 4 weeks (Figure 4.3A) or 8 weeks of age (Figure 4.3B) 
significantly decreased the percentage of degranulated mast cells in NMS bladders, 
compared to sedentary or baseline counterparts.  Exercise moderately decreased the 
percentage of degranulated mast cells in naïve bladder; however, the impact was not 
significant. 
Exuded mast cell granules contain the secretory protein tryptase, which can bind 
and activate PAR2 located on adjacent free nerve endings (363, 414).  Protein levels of 
PAR2 were moderately increased in sedentary NMS bladder; however, exercise 
beginning at 4 weeks of age significantly reduced PAR2 protein levels in NMS bladder 
compared to NMS-Sed (Figure 4.4A).  The mRNA levels of PAR2 were also significantly 
reduced in NMS-Ex bladder compared to NMS-Sed levels (Figure 4.4B).  Exercise had 
no impact on PAR2 protein or mRNA levels in naïve bladder. 
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Figure 4.3  
 
 
 
 
 
 
 
 
 
 
 
131 
 
Figure 4.3  The extent of mast cell degranulation was determined in bladders from 
neonatal maternal separation (NMS) and naïve mice that underwent early (A) and late 
(B) exercise interventions. Sedentary NMS mice in both experiments exhibited a 
significant increase in the percentage of degranulated mast cells in the bladder, 
compared to sedentary naïve counterparts. Exercise beginning at 4 weeks of age (A) or 
8 weeks of age (B) significantly decreased the percentage of degranulated mast cells in 
female NMS bladders. Brackets indicate a significant impact of NMS (*,** p<0.05, 0.01), 
exercise (###, #### p<0.001, 0.0001) or an NMS/exercise interaction (+,++ p<0.05, 
0.01), two-way ANOVA; *,** p<0.05, 0.01 vs. naïve, ###, #### p<0.001, 0.0001 vs. 
sedentary, Bonferroni posttest.  
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Figure 4.4  
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Figure 4.4  The protein and mRNA levels of the tryptase receptor, protease-activated 
receptor 2 (PAR2), were evaluated in the bladders from neonatal maternal separation 
(NMS) and naïve mice that underwent late exercise intervention. A) PAR2 protein levels 
were moderately increased in sedentary NMS bladder.  Exercise beginning at 8 weeks 
of age significantly decreased both protein (A) and mRNA levels of PAR2 in NMS 
bladder (B).  Bracket indicates a significant impact of NMS (*p<0.05), exercise (#, 
##p<0.05, 0.01) or an NMS/exercise interaction (+p<0.05) two-way ANOVA; *p<0.05 vs. 
naïve, ##p<0.01 vs. sedentary, Tukey’s posttest.  
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Exercise influences hippocampal gene expression 
To evaluate the impact of exercise on early life stress-imposed influences on 
limbic regulators of the HPA axis, we evaluated the hippocampal mRNA levels of BDNF 
and GR in sedentary and exercised NMS and naïve mice from the late exercise group.  
Exercise beginning at 8 weeks of age significantly increased BDNF expression in the 
hippocampus of both naïve and NMS mice (Figure 4.5A) compared to their sedentary 
counterparts.  Meanwhile, NMS significantly increased GR expression in the 
hippocampus; however, no significant effects of exercise were observed in either naïve 
or NMS mice (Figure 4.5B). 
Exercise influences altered reward behavior in NMS mice 
Previous studies have shown that the psychopathology associated with 
behavioral indicators of depression (415, 416) including anhedonia (417), and sensitivity 
of reward pathways (416, 418), have defined neurodevelopmental origins, which are 
associated with dysfunction of the HPA axis (65, 350, 419).  In a two-choice preference 
test, sedentary NMS mice consumed a significantly greater volume of 1% sucrose than 
their naïve counterparts (Figure 4.6A).  Exercise beginning at 4 weeks of age increased 
sucrose consumption only in naïve mice, with a modest increase in NMS mice (Figure 
4.6A).  No significant difference in total volume of liquids consumed (drinking water and 
sucrose combined) was observed between groups (data not shown).  A significant 
correlation was observed between sucrose preference and micturition frequency only in 
NMS mice, such that lower sucrose preference correlated with greater micturition 
frequency (Figure 4.6B).  Running distance was calculated as a measure of reward 
behavior and NMS mice given running wheels at 4 weeks of age ran significantly  
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Figure 4.5  
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Figure 4.5  The mRNA levels of brain-derived neurotrophic factor (BDNF) and 
glucocorticoid receptor (GR) were measured in the hippocampus from neonatal 
maternal separation (NMS) and naïve mice that underwent late exercise intervention. A) 
No difference in hippocampal BDNF mRNA levels were observed between sedentary 
NMS and naïve mice; however, exercise beginning at 8 weeks of age significantly 
increased BDNF mRNA levels in the hippocampus of both naïve and NMS mice.  B) 
NMS had a significant overall impact on increasing GR mRNA levels in the 
hippocampus.Late exercise did not have an impact on GR mRNA levels in either naïve 
or NMS hippocampus. Bracket indicates a significant impact of NMS (*p<0.05) or 
exercise (###p<0.001) two-way ANOVA; ## p<0.01 vs. sedentary, Tukey’s posttest.  
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Figure 4.6  
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Figure 4.6  Reward behaviors were measured in naïve mice and those that underwent 
neonatal maternal separation (NMS) to determine functional output of the hippocampus 
and the influence of an early or late exercise intervention. A) In a two-choice preference 
test, sedentary NMS mice consumed significantly more sucrose than their naïve 
counterparts.  Exercise beginning at 4 weeks of age significantly increased sucrose 
consumption in only naïve mice. B) A significant correlation between sucrose 
preference and void frequency was observed in female NMS mice, such that increased 
micturition frequency correlated with decreased sucrose preference. C) NMS mice given 
running wheels at 4 weeks of age ran significantly shorter distances per day (km/day) 
compared to naïve mice (p=0.0441)  D) NMS mice given running wheels at 8 weeks of 
age trended toward an increase in distance ran (km/day) compared to naïve mice 
(p=0.0809). A: Bracket indicates a significant impact of NMS (*p<0.05) or exercise 
(##p<0.01), two-way ANOVA; #p<0.05 vs. sedentary, Tukey’s posttest. B: *p<0.05, 
Pearson correlation.  C, D: Two-way RM ANOVA. 
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shorter distances per day (km/day) compared to their naïve counterparts across the 
study (Figure 4.6C); whereas late exercise NMS mice trended toward an increase in 
average distance ran per day (km/day) compared to naïve mice (Figure 4.6D). 
Late exercise reverses evidence of somatic comorbidities associated with HPA axis 
dysfunction 
Somatic co-morbidities are commonly experienced by IC/PBS patients and are 
associated with dysfunction within the HPA axis or limbic circuits (420, 421).  Here, we 
evaluated forepaw mechanical sensitivity and mast cell degranulation within the dura 
mater as correlates to the musculoskeletal dysfunction exhibited by fibromyalgia and 
migraine patients, respectively.  Forepaw mechanical sensitivity was significantly 
increased in NMS-Sed mice compared to naïve-Sed at 8 weeks of age, but after 4 
weeks of exercise, forepaw sensitivity was no longer significantly different between 
NMS-ex and naïve-Ex.  Naïve-Sed was significantly more sensitive compared to both 
NMS-Ex and naïve-Ex after 4 weeks of exercise, but the withdrawal thresholds in NMS-
Sed remained significantly decreased compared to naïve-Sed (Figure 4.7A).  A greater 
percentage of mast cells were degranulated in NMS-Sed dura mater compared to 
naïve-Sed (Figure 4.7B).  This difference was not observed in NMS-Ex animals 
exercised at 8 weeks of age.  No significant impact of NMS or exercise was observed 
on PAR2 protein levels in the dura mater (Figure 4.7C). 
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Figure 4.7 
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Figure 4.7  Forepaw mechanical sensitivity and dural mast cell degranulation were 
evaluated as phenotypic markers of somatic comorbidities in mice that underwent 
neonatal maternal separation (NMS). A) Sedentary NMS mice exhibited significant 
forepaw mechanical allodynia, which was reversed following 4 weeks of exercise 
beginning at 8 weeks of age. A significant increase in forepaw mechanical sensitivity 
was observed in sedentary naïve mice. Two-way RM ANOVA with Bonferroni posttest; 
**p<0.01 vs. naïve,  ####p<0.0001 vs. baseline.  B) The percentage of mast cells with 
evidence of degranulation was significantly elevated in the dura mater of sedentary 
NMS mice, compared to sedentary naïve mice. Exercise beginning at 8 weeks of age 
significantly decreased the percentage of degranulated mast cells present in NMS dura 
mater.  Bracket indicates a significant NMS/exercise interaction (p<0.05) two-way 
ANOVA with Bonferroni posttest.  *p<0.05 vs. naïve-Sed, ####p<0.0001 vs. NMS-Sed. 
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4.5 Discussion 
Voluntary physical activity and exercise training exerts a wide range of metabolic, 
neuroendocrine, and neurobiological effects.  While exercise physiology has been 
studied for many decades, the full potential of health benefits derived from exercise has 
not been explored.  Specifically, no published studies have evaluated the impact of 
exercise on animal models of chronic urogenital pain.  For several decades NMS has 
been used to investigate long-term changes in behavior and physiology resulting from 
early life stress, including alterations in limbic, reward, and stress circuitry-central brain 
regions (106, 185, 186), areas that are also heavily impacted by exercise (187). 
Clinically, exercise reduces the effects of depression and anxiety and associated 
perceptions of pain (33-35).  In this chapter, we investigated the efficacy of an early or 
late exercise intervention on reversing NMS-induced behavioral and molecular changes.  
Clinically, IC/PBS is characterized by recurrent pain in the bladder or surrounding 
region and at least one additional urological symptom such as frequency, urgency, or 
nocturia (422).  In the present study, we quantified bladder sensitivity by measuring 
VMR during UBD in NMS and naïve mice that were either housed in cages with or 
without free access to running wheels beginning at two different experimental time 
points.  In both paradigms, NMS-Sed mice at 8 weeks of age displayed significantly 
increased VMR during UBD as compared to their naïve-Sed counterparts, confirming 
our results in chapter 3 that NMS induces long-lasting urinary bladder hypersensitivity in 
female mice.  Early exercise animals were given access to running wheels at 4 weeks 
of age to evaluate the potential for exercise to prevent an adult-onset phenotype 
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whereas late exercise animals were given access to running wheels at 8 weeks of age 
after the adult-onset phenotype was established.  Introducing running wheels at 4 
weeks of age prevented the onset of bladder hypersensitivity, as the VMR during UBD 
was not significantly different between naïve-Ex and NMS-Ex mice.  Likewise, NMS-Ex 
mice given access to running wheels after the establishment of bladder hypersensitivity 
at 8 weeks of age exhibited a significantly lower VMR during UBD, as compared to their 
baseline measurements, and were not significantly different from naïve-Ex mice.  
Furthermore, NMS-Sed, but not NMS-Ex mice exhibited polyuria, measured as 
increased voiding events over a 1 h testing period, compared to their naïve 
counterparts.  Together, these data suggest that voluntary exercise is capable of both 
preventing and reversing NMS-induced bladder hypersensitivity and micturition 
frequency. 
Mast cells have been shown to contribute to inflammatory states in a variety of 
diseases associated with stress onset, exacerbation, or predisposition (363).  
Circulating or local glucocorticoids and other stress ligands can stimulate the release of 
numerous pro-inflammatory mediators such as histamine, tryptase, or proteases from 
mast cells (120, 423).  Mast cells are part of the innate immune response and primarily 
reside in tissues interfacing with the environment, including the integument, meninges, 
and respiratory-, gastrointestinal-, and genitourinary tracts (94-96).  Many studies have 
found increases in mast cell infiltration in biopsies of affected tissue from IC/PBS 
patients (291, 424-428).  The observed increase in mast cell degranulation in NMS 
bladders both in this chapter and chapter 3 suggests downstream dysregulation of 
neuroimmune regulators of visceral inflammation.  Mast cell-released tryptase binds to 
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and activates PAR2, which is located on neuropeptide-containing nerve endings in the 
viscera, and has been shown to drive visceral hypersensitivity (124, 125, 429).  As in 
chapter 3, we observed an increase in PAR2 protein levels in NMS-Sed bladder, 
suggesting an increase in the “nerve-mast cell axis”, which is thought to contribute to 
chronic pain. 
Clinically, exercise has been shown to improve markers of chronic inflammation 
(154, 430) and here we report that voluntary exercise, beginning at 4 or 8 weeks of age, 
decreased mast cell degranulation in NMS bladder.  Furthermore, we observed that 
exercise beginning at 8 weeks of age decreased both protein and mRNA levels of PAR2 
in NMS-Ex bladder, compared to NMS-Sed mice.  Previous work has shown that 
intravesicular installation of zymosan during the second postnatal week resulted in adult 
bladder hypersensitivity without a concordant change in mast cell degranulation (325).  
Our observation of increased mast cell degranulation in NMS bladders suggests that 
stress and injury experienced during neonatal development induce bladder 
hypersensitivity via different mechanisms, with the former likely recruiting the 
involvement of higher brain centers.  This is further supported by our findings showing 
that bladder hypersensitivity, over-activity, and associated mast cell degranulation can 
be prevented or reversed by exercise, which has been shown to impact activity of the 
hippocampus and downstream activation of the HPA axis in exercised individuals (431). 
Clinically, early life stress reduces hippocampal volume (432) and functional 
connectivity within limbic structures of individuals with co-morbid depression (433), and 
improper hippocampal development systemically disinhibits the HPA axis (434) in a 
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BDNF-dependent manner.  In concordance with these findings, NMS, adult stress, and 
increased glucocorticoids have been shown to decrease BDNF expression specifically 
in the hippocampus (415, 435-437), and similar findings were reported in human 
patients with histories of childhood trauma (438, 439).  Diminished neurogenesis, 
specifically in the dentate gyrus of the hippocampus, blunts negative feedback on the 
HPA axis and induces depression-like behaviors in rodents (440).  The present study 
demonstrates increased GR mRNA levels in the hippocampus of mice subjected to 
NMS with no corresponding change in BDNF mRNA levels.  This observation is striking 
in that dexamethasone treatment or genetic overexpression of GR has been shown to 
increase hippocampal BDNF mRNA or protein levels and, conversely, knockdown of 
GR decreased BDNF protein content in the hippocampus (369, 370).  Previous studies 
have shown evidence of epigenetic changes indicative of glucocorticoid resistance (441, 
442), which may be at play in our NMS mice.  GR resistance may be described in terms 
of decreased affinity for the ligand or ability to translocate to the nucleus for binding 
glucocorticoid response elements (443); for instance, phosphorylation states of the GR 
in response to stress may mediate GR responsiveness (444).  Deficits in negative 
feedback can also be related to elevations in GR expression such as those observed in 
animal models of post-traumatic stress syndrome (PTSD).  For instance, female 
patients with PTSD specifically associated with sexual or physical abuse display lower 
circulating cortisol compared to control (445) while increased GR (446) and decreased 
BDNF (447) expression in the hippocampus have been observed in animal models.  
Understanding altered GR function, such as evidence of glucocorticoid resistance, is of 
critical importance to understanding disorders characterized by impaired HPA axis 
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activity and negative feedback.  While hippocampal GR mRNA levels were unaffected 
by exercise, they were increased in NMS mice compared to naïve, but BDNF mRNA 
levels were increased in both naïve-Ex and NMS-Ex hippocampus, suggesting 
increased neurogenesis or plasticity within the hippocampus and provides evidence of a 
mechanism by which exercise mediates positive effects.  The interplay between BDNF 
and glucocorticoids within the hippocampus is complex (366), but given that BDNF 
promotes neurogenesis and synaptic plasticity within circuitry that also regulates the 
HPA axis, reinstatement of proper HPA axis negative feedback may be one mechanism 
by which NMS-induced behavioral phenotypes are ameliorated by exercise. 
Changes in limbic circuitry and the emotional response to reward have long been 
studied by exercise physiologists and may provide insight into specific mechanisms by 
which exercise could improve the limbic regulation of the HPA axis following NMS.  
Behavioral and hippocampal changes in rats exposed to prenatal glucocorticoids (448) 
or NMS (272) were shown to be normalized with exercise.  Clinically, exercise has also 
been shown to improve symptom scores of depression and anxiety (195-197), including 
depression among fibromyalgia patients (193, 194).  In the present study, NMS-Sed 
mice consumed significantly more sucrose likely reflecting diminished processing of 
rewarding stimuli, a finding also observed in depressed individuals (449).  A significant 
correlation was found between anhedonia and voiding events only in NMS mice, such 
that decreased sucrose preference corresponded with increased voidance events, 
suggesting that behaviors indicative of depression and polyuria are comorbid in NMS 
mice.  This observation persisted in NMS-Ex mice despite a decrease in the number of 
voidances in this population, indicating that voluntary exercise evoked a systemic 
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improvement in NMS-related behaviors rather than specifically improving bladder 
sensitivity and function alone. 
Interestingly, average distances ran per week differed between naïve and NMS 
mice in an age-dependent manner.  In the early exercise paradigm, NMS mice ran 
significantly shorter distances per week compared to naïve across the entire testing 
period.  In contrast, during the late exercise paradigm, we observed that NMS mice 
trended toward increased running distance per week compared to naïve.  Interpretation 
of this data is somewhat complicated by the housing situation between the two 
paradigms, as early exercised mice were pair-housed to avoid potential complications 
arising from social isolation and late exercised mice were singly housed.  The elevated 
running distance in the naïve animals observed in early exercise might be due to dual 
runners in the cage while NMS animals ran in tandem or one did not run at all.  
However, we do not believe the latter to be the case as early exercise improved 
behavioral measures of bladder sensitivity, micturition frequency, and forepaw 
sensitivity across all animals in the pair-housed NMS group.  Naïve animals that were 
singly housed in the late-exercise paradigm ran an average distance of 5-10 km/day 
while pair-housed animals in the early exercise paradigm also ran an average distance 
of 5-10 km/day, suggesting that the effects observed were due to differences in the 
running patterns of NMS, rather than naïve, mice.  Together these data suggest age-
dependent alterations in the sensitivity of reward pathways in NMS mice.  Additional 
studies should be undertaken to elucidate specific regulatory mechanisms that might be 
driving these changes. 
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Early life adversity increases the likelihood of comorbid symptomology or 
diagnoses of multiple functional pain disorders and is a significant risk-factor for the 
development of psychiatric disease in adults (265, 266, 450, 451).  Furthermore, 
estimates suggest up to 80% of individuals with severe cases of depression and 90% of 
individuals with severe cases of generalized anxiety have additional psychiatric co-
morbidities, including affective, anxiety, and substance abuse disorders (452).  Patients 
with IC/PBS are not only at increased risk of developing mood disorders, but also 
chronic pain in non-pelvic regions, such as that experienced by patients diagnosed with 
fibromyalgia or migraine (12, 453).  The data from this chapter suggest that NMS may 
be an initiator of behaviors reflecting these comorbid, centralized pain conditions.  To 
the best of our knowledge, this is the first report of forepaw hypersensitivity following 
NMS.  While hindpaw sensitivity has previously been investigated in NMS animals (150) 
and may in part be driven by spinal convergence of hind limb and pelvic organ 
innervation, hypersensitivity of the forepaw is unlikely to be attributed to dichotomous 
innervation or secondary convergence with the pelvic organs.  Cutaneous 
hypersensitivities in patients with CPP vary in regard to somatotopic organization (454-
456), but demonstrations of lower (457) and upper (458) extremity somatic sensitivity 
are observed, delineating forepaw sensitivity as a novel finding in NMS mice.  Exercise 
reversed the forepaw sensitivity observed in NMS-Sed animals and, strikingly, 
mechanical sensitivity of the forepaw was increased in naïve animals that remained 
sedentary over time, although not to the extent of NMS-Sed animals.  These data 
highlight an incredible point about behavioral studies in rodents that are otherwise 
natural runners.  Mice are mobile in the wild (459) and while the limitations of laboratory 
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manipulation cannot take into account all aspects of the natural environment, it is likely 
that the sedentary caging condition utilized in animal studies is a covariate that should 
be taken into account.   
 Broadening the impact of these findings, we also evaluated mast cell 
degranulation in the dura mater as a potential biomarker of migraine.  Animal models of 
migraine are often chemically induced by dural application of mast cell mediators known 
to sensitize meningeal nociceptors (460).  Here we report that, indeed, mast cell 
degranulation was significantly elevated in dura from NMS-Sed mice, compared to 
naïve-Sed mice, and that exercise beginning at 8 weeks of age significantly reduced the 
percentage of degranulated mast cells in the dura of NMS-Ex mice, compared to NMS-
Sed.  As mast cells in particular are thought to contribute to the pathophysiology of 
migraine (461), reducing their state of degranulation with exercise as demonstrated 
here has potential implications for migraineurs, particularly those whom also suffer from 
CPP.  These data, again, support the theory that voluntary exercise resulted in systemic 
improvements in comorbid sensitivity and molecular markers of neuroendocrine 
dysfunction that are likely being driven by improper regulation of the HPA axis. 
4.6 Conclusion 
 This study showed that maternally-separated adult female mice displayed 
increased urinary bladder sensitivity and micturition rate.  Consumption of sucrose was 
greater in NMS mice, the preference of which correlated with urinary dysfunction, and 
changes in sucrose consumption and running distance suggest NMS impacted reward 
pathways.  Peripherally, increased mast cell degranulation and PAR2 protein levels 
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were elevated in NMS bladder.  Four weeks of voluntary exercise beginning at either 4 
or 8 weeks of age abolished many of the abnormal behavioral and molecular changes 
attributed to NMS, including forepaw sensitivity and dura mater mast cell degranulation, 
findings reflective of comorbid hypersensitivity.  Centrally, voluntary exercise 
significantly increased BDNF mRNA levels in the hippocampus of both naïve and NMS 
mice.  Combined with our data from the previous two chapters, our results here further 
suggest that hippocampal input to the HPA axis may be disrupted in NMS mice and 
voluntary exercise can prevent or reverse negative outcomes following early life stress. 
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Significant subsets of female patients with functional pelvic pain disorders, 
including the urogenital disorders IC/PBS and vulvodynia, report a history of adverse 
childhood events and exacerbation of their symptoms during stressful periods (227, 
228).  This disrupted stress response has been attributed to dysfunction within the HPA 
axis, which regulates the stress response and influences the perception of pain.  
Stressors experienced early in life, such as childhood neglect or abuse, low 
socioeconomic status, and witnessing domestic violence, parental discord, or crime in 
the home, profoundly impact behavior and also serve as risk factors for developing 
functional pain disorders (257, 266, 275-278, 284, 462).   
Understanding the links between early life stress and adult-onset pelvic pain has 
been the purpose of the studies described in this dissertation.  Despite an increased 
prevalence for CPP syndromes and comorbid mood disorders in women, animal models 
of female CPP are lacking.  In pursuit of this question, the presented studies used an 
animal model of early life stress, NMS, as a means to study behaviors reflecting the 
clinical conditions observed in CPP.  Experiments in this dissertation evaluated the 
impact of NMS on visceral and somatic sensitivities, anxiety-like and depression-like 
behaviors, and the response to acute stressors in adulthood.  These studies expanded 
upon our understanding of these altered behaviors by evaluating the expression of 
factors that regulate the HPA axis within the central nervous system, including the limbic 
structures.  These studies went on to investigate the downstream effects of a 
dysregulated HPA axis on the immune system, specifically mast cell degranulation, 
cytokine expression, and peripherally-expressed stress ligands.  The final study in this 
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dissertation evaluated the potential for exercise to prevent or reverse the aberrant 
behaviors attributed to NMS. 
5.1 NMS alters adult behavior 
Psycho-emotional components are often observed in conjunction with CPP 
syndromes.  A national study found prevalence rates and severity of chronic pain 
conditions with comorbid depression were twice as high in women, as compared to men 
(463).  Among women, depression was related to severity of pain, whereas, among 
men, depression was related more to functional impairment (464). Two generations 
ago, these correlations led medical professionals to attribute a patient’s pain to 
peripheral manifestations of a psychogenic origin (465-468). 
Epidemiological evidence suggests a common rate of comorbidity between 
urogenital pain syndromes and chronic pain syndromes affecting other body locations, 
such as fibromyalgia, temporomandibular joint disease, and migraine, as well as with 
mood disorders such as depression (22).  While a number of studies have clearly 
indicated strong correlations between adverse experiences during childhood and 
psychiatric impairment in adulthood, behavioral changes have largely gone 
understudied in the female mouse model of NMS (58, 395, 469-473).  Therefore, 
investigating the impact of NMS on adult behaviors indicative of anxiety or depression 
was an important aim in this dissertation.  As reported in chapter 2, following exposure 
to an adult stressor (VBD), female NMS mice spent a significantly higher percentage of 
their total distance traveled in the perimeter of an open field, compared to naïve mice, 
indicating an increase in anxiety-like behavior. Studies in chapter 4 of this dissertation 
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evaluated anhedonic behaviors in NMS mice, defined as the blunted capacity to 
experience pleasure, a hallmark characteristic of major depressive disorder (474).  A 
diminished lack of interest in palatable food was determined by a two-choice sucrose 
preference test, which has been shown to be an indicator of an anhedonic state in 
rodents (475).  This lack of enthusiasm for normally rewarding behaviors such as 
consumption of sucrose may be reversed by administration of antidepressant drugs 
(476, 477) and correlates to successful pharmacological anti-depressant 
responsiveness in humans (478).  Interestingly, sedentary NMS mice consumed greater 
volumes of sucrose compared to their naïve counterparts.  While the impact of stress on 
regulation of appetite was previously discussed, this finding likely reflects metabolic 
derangement rather than absence of anhedonia.  However, further analysis of the data 
found significant correlations between decreased sucrose preference and severity of 
polyuria in NMS, but not naïve mice.  Together, these findings suggest early life stress 
negatively impacts mood in adulthood, comorbidities common in CPP. 
In addition to mood disorders, women diagnosed with urogenital pain syndromes 
are more likely to have chronic pain in other body locations.  Somatic hypersensitivities 
may be measured by a range of quantitative tests which include measuring thresholds 
to temperature, mechanical, or ischemic pain, findings of which have all been found in 
association with CPP syndromes (457) and IC (479). 
Cutaneous hypersensitivities in patients with CPP vary in regard to somatotopic 
organization (454-456).  Zhou et al., (457) found that IBS patients demonstrated 
decreased threshold and tolerance to cold and thermal stimuli on the lower but not 
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upper extremity.  There were no differences in mechanical cutaneous sensitivity among 
IBS patients compared to healthy control, but tolerance and pain threshold was 
significantly decreased in IBS patients during tourniquet exsanguination of the upper 
extremity.  They also reported that immediately following the ischemia and cold 
sensitivity tests, serum cortisol of IBS patients was significantly increased over baseline 
levels, as well as compared to that of healthy controls that underwent the same 
procedure.  Another study reported thermal hyperalgesia in IBS patients compared to 
healthy controls on both upper and lower extremities (458).  Viscero-visceral and 
viscero-somatic sensitivities are also found among patients with CPP syndromes.  
Female IBS patients hypersensitive to colorectal distension also exhibited increases in 
rectal pain scores during somatic stimulation of a lower extremity (480).  Similar 
dysfunction in pain facilitation has been found in patients with fibromyalgia and IC/PBS 
(479, 481), especially between organ interactions with common spinal projections.  
Women diagnosed with both dysmenorrhea and urinary calcinosis had more 
genitourinary and referred abdominal hyperalgesia than women with endometriosis or 
urinary calcinosis alone.  Interestingly, alleviation of symptoms associated with one 
diagnosis not only improved symptoms associated with the other but also improved the 
referred somatic hyperalgesia, a finding which implicates the importance of spinal 
convergence (482).  However, unlike organically derived chronic pain, functional pain 
disorders are associated with no apparent organ pathology, have elusive onsets, and 
respond poorly to traditional therapies.  In the work presented in this dissertation, female 
NMS mice developed somatic hypersensitivities as demonstrated by decreased 
withdrawal latencies to thermal stimuli and decreased withdrawal thresholds to 
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mechanical stimuli applied to the hindpaw.  The sensitivity to thermal and mechanical 
stimuli was observed both at baseline and following VBD, a stressful event in adulthood.  
Uncertainty existed whether the somatic sensitivity observed in this model was due to 
convergence in lumbosacral spinal processing between visceral and lower extremity 
afferents or due to widespread sensitization.  Therefore, mechanical sensitivity of the 
forepaw was tested in chapter 4 of this dissertation.  Indeed, sedentary NMS mice 
exhibited forepaw hypersensitivity, a novel finding in stress neurobiology that suggests 
a widespread sensitization in the NMS model, extending beyond the lumbosacral spinal 
region.    
 Neonatal stress or injury in rodents produces a phenotype in adulthood similar to 
what is seen in IBS patients, such as visceral hyperalgesia, increased firing rates of 
dorsal horn neurons responding to colonic distension, and increased expression of TRP 
channel subtypes in sensory neurons that innervate the colon (146-149).  These studies 
have largely concentrated on abdominal withdrawal or VMR during CRD in male rats.  
Equivalent mouse models have been less consistent (311, 318, 319).  One study of 
male mice that deviated from the standard NMS model by combining unpredictable 
NMS with unpredictable maternal stress showed increased VMR during CRD in 
adulthood (319).  The traditional NMS model has otherwise been shown to increase 
colorectal hypersensitivity, aberrant responses to future stress, and susceptibility to 
infection or experimental colitis in adulthood (146, 229, 230).  While NMS is well 
established in rats, until the work presented in this dissertation, it has not been used to 
study the effect on urogenital hypersensitivity in either rats or mice.  By quantifying the 
VMR during organ distension, the data presented here demonstrated both vaginal and 
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urinary bladder hypersensitivity in NMS mice compared to naïve.  Furthermore, acute 
stress in the form of WAS significantly enhanced the bladder hypersensitivity observed 
in NMS mice.  On the other hand, NMS mice displayed a diminished VMR during CRD 
compared to naïve, a finding that persisted following acute stress.  Women commonly 
exhibit comorbidities between IC/PBS and gynecological pain, but the mechanisms 
underlying this comorbidity are unclear (313, 483, 484).  Anatomically, the distal vagina, 
vulva, and bladder arise from a more common embryological origin compared with the 
hindgut (485-487).  While dichotomizing afferents have been reported between the 
bladder and colon in dorsal root ganglia (488), the vagino-vesicosphincteric reflex, 
which inhibits urinary bladder activity and increases contraction of urethral sphincters 
during vaginal distension, is evidence of neurological circuitry within the genitourinary 
system, a finding which is less apparent between the urogenital organs and colon (489, 
490).  In support of NMS-induced urogenital specific effects, the studies presented in 
this dissertation revealed increased expression of cytokines and growth factors in 
vaginal and bladder tissue that largely spared the colon in comparison (chapter 2, 3).  In 
the context of pelvic sensitivity, this work provides an anatomical and molecular basis 
for mechanisms of shared stress-induced pathophysiology between the urogenital 
organs, as well as evidence of comorbid somatic sensitivities and mood disorder. 
5.2 NMS influences central regulation of the HPA axis 
NMS has generally been shown to increase the output of the HPA axis, as 
evidenced by stimulation of anxiety-like behaviors and increased duration of ACTH and 
CORT release following a stressful event (64, 241-243).  Activity of the HPA axis is 
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regulated by positive and negative feedback from glucocorticoids both within the 
hypothalamus and from higher limbic structures.  Under homeostatic conditions, the 
amygdala and hippocampus stimulate and inhibit CRF production and secretion from 
the hypothalamus, respectively.  Generally, these limbic regions work in opposition to 
one another to control the activity of the HPA axis (65, 90).   
Hippocampal inhibition of the HPA axis can be compromised by chronic stress or 
long-term administration of corticosteroids (65).  Decreased glucocorticoid feedback to 
the hippocampus due to either 1) decreased receptor expression or 2) GR resistance 
(93), reduces descending inhibition onto the hypothalamus and results in increased 
CRF release and subsequent glucocorticoid production (65, 90).  Decreased 
hippocampal MR expression has been previously reported to occur following a single 
sustained acute stress in rats and has been theorized to contribute to post-traumatic 
stress disorder (338).  Even within a given anatomical area, the concept of balanced 
activity from distinct brain regions extends to a molecular level when regarding the 
GR:MR ratio and adaptability to stress (491).  The fast- and slow-acting activities of MR 
and GR in the amygdala, hippocampus, or prefrontal cortex typically serve to promote 
energy redistribution, hone focus, increase vigilance, and enhance learning or memory 
and are essential in the mammalian adaptability to stress.  Maladaptive responses, on 
the other hand, are related to improper MR:GR expression, particularly in higher regions 
that regulate the HPA axis.  For instance, genetic disruption of GR expression in the 
PVN of the murine hypothalamus increased CORT, impaired negative feedback via 
dexamethasone suppression testing, and increased adult adiposity, but did not 
influence anxiety-like or despair-like behaviors (492).  On the other hand, conditional 
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GR knockout model in the forebrain, hippocampus, and basolateral/medial amygdala, 
but not the PVN, resulted in a depression- and anxiety-like phenotype, impaired 
negative feedback onto the HPA axis, and interestingly, decreased MR expression in 
the hippocampus after restraint stress (493).  Functionally, GR knockdown within the 
hippocampal neurogenic niche accelerated neuronal differentiation, migration, 
spinogenesis, and synaptic contacts (494).  Similarly, diminished neurogenesis and 
accelerated atrophy in the Cornu Ammonis 3 and 1 and the subiculum subfields of the 
hippocampus, the primary circuit that provides inhibitory influence over the PVN (495), 
was associated with CORT exposure associated with chronic stress conditions, 
including early life adversity (496, 497).  Thus, characterization of GR and MR 
expression in limbic structures and the hypothalamus was an important finding in the 
NMS model presented in this dissertation.  As shown in chapter 2, expression of GR 
was increased in the hypothalamus, unchanged in the amygdala, and decreased in the 
hippocampus of NMS mice.  Likewise, expression of MR was decreased in NMS 
hippocampus yet unchanged in hypothalamus and amygdala.  Similarly, following WAS, 
expression of GR and MR were increased in NMS and naïve hypothalamus, but 
decreased in the NMS hippocampus (chapter 3).  Together, these studies provide 
evidence for corticosteroid receptor resistance in the hypothalamus and diminished 
negative feedback from the hippocampus, which ultimately decreases descending 
inhibition onto the HPA axis.  Targeting the dysfunctional regulation of the HPA axis 
from the hippocampus could provide a mechanism by which to normalize HPA axis 
activity and restore downstream homeostasis within the pelvic viscera, and ultimately, 
improve chronic pelvic pain. 
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5.3 Impact of NMS on the pelvic viscera 
Immunoendocrine signaling in the periphery is modulated by downstream 
signaling from the HPA axis and previous studies have shown that regulators of this 
process differ across the pelvic organs.  On one hand, CRF1 has been implicated in 
colorectal hypersensitivity and gut-barrier dysfunction, which results in the presentation 
of gut luminal antigens to resident immune cells by toll-like receptors (318, 386).  In fact, 
the CRF1 antagonist GW876008 completed phase II clinical trial as a potential treatment 
for IBS, and is currently under investigation for unexpected, off-target side effects (498, 
499).  However, CRF2 antagonism blocked the release of the proinflammatory cytokine 
IL6 from cultured cardiomyocytes (387) and expression of TNFα and IL10 were 
increased in cytotrophoblast cells by a CRF2-mediated mechanism (388).  Similarly, 
stress-induced bladder hypersensitivity and vascular permeability have also been 
shown to be driven by a CRF2-, rather than a CRF1-, mediated mechanism and 
peripheral expression of the cytokines TNFα and IL10 are also upregulated by a CRF2-
mediated mechanism (144, 387, 388).  Furthermore, activation of peripherally versus 
centrally expressed CRF1 and CRF2 is not as well delineated in function.  Most CRF 
receptor activation is coupled to Gαs and cAMP signaling, but there are examples of 
CRF receptor expression in testis and placenta that instead activates MAPK, 
intracellular Ca2+/PKC, or IP3 pathways and stimulation of such divergent signaling 
cascades as to include NF-κB, ERK1/2, GSK-3β, and Wnt/β-catenin pathways (145, 
500, 501).  The G-protein subtype involved and subsequent downstream signaling 
cascade is also tissue dependent (501).  For instance, in the hippocampus and other 
neuronal cells such as pituitary corticotrophs, CRF receptor signaling leads to activation 
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of ERK1/2, but in cell cultures of female reproductive tissue such as breast, uterus, and 
placenta, CRF receptor signaling leads to inhibition of ERK1/2 cascades (502-505).  It is 
still unclear which endogenous CRF receptor ligands are involved in these processes.  
Opposing tissue specific effects of CRF receptor agonists have also been shown 
regarding activation or inhibition of immunomodulatory activity, intracellular signaling 
cascades, and gene expression (371, 387, 506, 507).  Acknowledgement of the 
peripheral neuroendocrine response to stress is becoming clearer, but localization 
across cell types in various tissues remains uninvestigated.  The differing intracellular 
pathways stimulated by CRF receptor subtypes might account for the differential impact 
of stress across the pelvic organs. 
Despite their potential involvement in stress-related pathologies and 
immunomodulatory effects, expression characteristics of peripheral stress ligands and 
their receptors and the mast cell-nerve axis had previously not been investigated in 
early life stress-induced urogenital hypersensitivity.  While work presented in chapter 2 
of this dissertation does not necessarily suggest that the increased expression of the 
tested cytokines and growth factors was due to a CRF2 or CRF1 mediated mechanism, 
differential patterns of such expression between NMS vagina, bladder, and colon 
emerged.  This differential impact of NMS and adult stress on the expression of factors 
representing the local inflammatory state of the viscera was also reflected in data 
presented in chapter 3.   
Mast cells have been shown to contribute towards the visceral inflammation and 
pain associated with nearly all CPP-related disorders and have specifically been 
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investigated in IC/PBS for several decades (291, 411, 424-428, 508). Previous studies 
have shown that mast cells are acutely responsive to CRF and other stress ligands, and 
that release of their contents helps drive neurogenic inflammation and increase local 
production of TNFα (105, 106, 119, 129).  Interestingly, we observed an initial decrease 
in the mRNA level of TNFα in the vagina of NMS mice that was significantly increased 
following VBD procedure (chapter 2). Mast cell activation also been shown to increase 
de novo synthesis and release of NGF (509), which has been shown to mediate stress-
induced gut-barrier dysfunction, influence plasticity in central pain circuitry, and has 
been suggested as a biomarker for IC/PBS (296, 510-514).  As shown in chapters 2 and 
3, NGF mRNA levels are increased in urinary bladder tissue of adult NMS mice.  
Increased infiltration and degranulation of mast cells in the NMS urinary bladder and 
vagina (chapter 3), but not colon (data not shown) were observed.  Furthermore, 
selective overexpression of NGF in the bladder has been shown to result in 
hyperreflexia, hyperinnervation, and increased mast cell infiltrates (170).  
Hyperexcitability of bladder afferents was also reported following intrathecal 
administration of NGF (171).  Behavioral indicators associated with experimental cystitis 
could be attenuated with systemically-administered NGF neutralizing antiserum or 
intravesicular infusion of a nonspecific Trk receptor antagonist (177) that together 
highlights a dominant role for this neurotrophin with direct relevance to IC/PBS patients 
(178).  Due to perpetuation by the nerve-mast cell axis, increased sensory innervation in 
the NMS urinary bladder and vagina should be analyzed in future studies. 
Secreted mediators from mast cells can lead to, among other signal transduction 
pathways, activation of nociceptor-expressed TRP channels, the chronic activation of 
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which can drive sensitization (515).  Mast cell paracrine functions involving 
degranulated tryptase and histamine binding to PAR and histamine receptors, 
respectively, have been shown to sensitize TRPA1 and TRPV1 in vivo (139, 142) and 
likely contributes to chronic functional pain (124, 125).  Furthermore, data presented in 
chapters 2 and 3 showed that NMS and WAS increased TRPA1 protein expression in 
bladder, while elsewhere, experimental cystitis has been shown to induce a TRPA1-, 
but not TRPV1-, dependent hyperalgesia (392).  The mRNA expression of metabotropic 
glutamate receptors was also upregulated primarily in bladder rather than lumbosacral 
spinal cord, of mice with experimental cystitis (516). Clinically, an increase in TRPV1-
immunopositive innervation was reported in biopsies of affected tissue from vulvodynia 
patients with dyspareunia (517).  Interestingly, this study also found increased TRPV1-
immunopositive innervation in skin samples from vulvodynia patients. A separate study 
evaluated widespread sensitivity in vulvodynia patients via injection of subdermal 
capsaicin in the upper and lower limbs and reported increased hyperalgesia and 
allodynia compared to controls (518).   
While the extent of systemically increased TRPV1, and/or TRPA1, expression in 
vulvodynia patients has yet to be determined, the contribution of TRP channels, and 
nociceptor sensitization in general, towards comorbid symptomology is likely attributed 
to downstream alterations in centrally-regulated stress responses (519, 520).  Indeed, 
vulvodynia patients given subdermal capsaicin exhibited evidence of dysautonomia in 
the form of increased resting heart rate and lower blood pressure, consistent with a 
hyperactive stress reaction (518).  Risk of vulvodynia is elevated among women with 
antecedent mood disorders (54), suggesting that higher levels of chronic stress among 
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these patients serves to increase symptom severity (55).  Indeed, vulvodynia patients 
demonstrate blunted serum cortisol cycles that manifests in a variety of emotional and 
physiological indicators (56).  Hyperalgesic responses to capsaicin and increased 
expression of TRPV1 in vulvodynia patients are well documented, but clinical studies 
have yet to evaluate the role of TRPA1 in CPP syndromes despite its established role in 
the development and maintenance of visceral hypersensitivity (149, 392, 521). Given 
that TRPA1 is almost exclusively co-expressed with TRPV1 by afferents innervating 
viscera and other deep tissues (522-525) it is likely that the changes within this afferent 
population among patients with CPP also reflect potential increases in TRPA1 
expression and/or function. 
5.4. Exercise as an intervention for NMS-associated phenotypes 
Recently, exercise been shown to confer protective benefits for neurological 
disorders such as Parkinson’s disease, Alzheimer’s disease, stroke, and traumatic brain 
injury (267-269).  Clinically, exercise reduces the effects of depression and anxiety and 
associated perceptions of pain (195-197, 199, 270, 271) and improves symptom 
severity in patients with IBS (198-203) and fibromyalgia (192-194).  Despite the general 
acceptance that exercise improves a wide variety of disease outcomes, little 
investigation has been done to evaluate the impact of exercise on animal models of 
many human diseases, including chronic pain disorders.  Voluntary wheel running has 
been shown to attenuate colorectal hypersensitivity exhibited by prediabetic mice (526), 
indicating that exercise has the potential to reverse visceral hypersensitivity; however, 
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the therapeutic potential of interventional exercise has not been evaluated in animal 
models of stress-associated pelvic pain. 
Exercise in rodents has been shown to attenuate neuromolecular and behavioral 
changes associated with a dysfunctional HPA axis induced either by hyperactive 
function or diminished negative feedback, the latter implicated in NMS-induced visceral 
hypersensitivity.  Prenatal exposure to glucocorticoids via dexamethasone injection in 
pregnant rats resulted in elevated levels of CORT and anhedonic-like behaviors in the 
adult offspring that were attenuated by a 4-week swimming exercise (448).  Running 
exercise also normalized altered behavior and hippocampal changes in Sprague-
Dawley rats that underwent NMS in the post-natal period (272).  Following NMS, rats in 
this study spent decreased amounts of time exploring either the center of an open field 
or the open arms of an elevated plus maze and also spent more time immobile in a 
forced swimming test, a behavior that has largely been shown to be responsive to anti-
depressant therapy (527). Both the NMS-induced behavioral findings and hippocampal 
gene expression changes were ameliorated by providing the rats access to running 
wheels beginning in the post-weaning period (272), likely due to exercise-induced 
restoration of negative feedback on the HPA axis or potentiation of dopaminergic 
reward in the mesolimbic system (70-72, 528-531).  Interestingly, this study also 
revealed that providing the animals a palatable, high-fat diet beginning in the post-
weaning period resulted in the same outcomes as providing access to running wheels.  
A wealth of studies have demonstrated that ghrelin, a gut-derived peptide known to 
stimulate food intake, is intimately involved in regulating behaviors related to food 
reward and promoting activity in the mesolimbic-dopaminergic reward centers 
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particularly in response to high-fat diet (532-541).  In keeping with these findings, we 
observed that sedentary NMS mice consumed greater volumes of sucrose compared to 
sedentary naïve animals (chapter 4).  Sucrose consumption was further increased in 
exercised animals; however, the underlying drive for increased sucrose intake could 
have been due to an increased caloric need. The effects of NMS on the hypothalamic 
regulation of appetite have not been explored, but mouse models of systemic disease 
that involve gene knockouts of appetite-regulators (542) highlight how this interaction 
might confound behavioral studies involving exercise, a physiology closely tied to 
metabolic state.   
Changes in limbic circuitry and the emotional response to reward have long been 
studied by exercise physiologists and may provide insight into mechanisms by which 
exercise could improve the limbic regulation of the HPA axis following NMS.  Improper 
hippocampal development resulting in HPA axis disinhibition has been shown to be 
induced by lentiviral knockdown of BDNF (434).  This implicates developmental BDNF 
expression as imperative in hippocampal management of HPA axis circuitry because 
the same chronic elevations in corticosterone were not observed when the lentiviral 
knock-down was administered later in life.   In concordance with these findings, NMS, 
adult stress, and increased glucocorticoids have been shown to decrease BDNF 
expression specifically in the hippocampus (415, 435-437) with similar findings in 
human patients with histories of childhood trauma (438, 439).  No statistically significant 
changes in BDNF expression were observed in NMS hippocampus compared to naïve 
at baseline or following WAS in the current study (chapter 3), but exercise did increase 
expression in both groups compared to their sedentary counterparts (chapter 4). 
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Exercise was also effective at either preventing or reversing the urinary bladder 
hypersensitivity, related polyuria, and mast cell degranulation resultant from NMS.  A 
similar pattern was observed in the forepaw sensitivity study (chapter 4) that 
demonstrated decreased sensitivity in the exercised groups compared to sedentary 
naïve mice, otherwise considered the control group.  Taken together, this provides 
evidence for one mechanism by which NMS-induced behavioral phenotypes might be 
ameliorated by an exercise-induced increase in BDNF and subsequent reinstatement of 
proper HPA axis negative feedback.  Ultimately, these data highlight an incredible point 
about behavioral studies in rodents that are otherwise natural runners.  Mice are mobile 
in the wild and while the limitations of laboratory manipulation cannot take into account 
all aspects of the natural environment, it is likely that the sedentary caging condition 
utilized in animal studies is a covariate that should be taken into account in the future. 
5.5 Conclusion   
Functional pelvic pain disorders, such as IC/PBS and vulvodynia, are diagnosed 
symptomatically in the exclusion of other, clinically identifiable pathologies. A disparate 
array of etiologies has been shown to underlie these disorders, including infection, 
peripheral sensory and/or motor neuron dysfunction, improper immune function, and 
psychological disturbances (278, 279, 543-545). As a result, patient populations display 
similar symptomology that manifests via different underlying pathology, partially 
explaining the difficulty in identifying effective treatment strategies.  Subsets of CPP 
patients are more likely to report histories of early life adverse events that, in turn, 
increase the risk of developing a CPP syndrome later on in life.  Understanding the 
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relationship between functional pain syndromes and early life stress is of vital 
importance considering current trends of early childhood adversity and the profound 
impact it imparts on adult health, disease, and mortality.  The work presented in this 
dissertation generated novel insight on how early life stress drives female urogenital 
pain, contributes to mood disorders, and alters neurodevelopment.  Finally, this work 
provides the first report of exercise as an intervention method for visceral pain, a finding 
that will be of particular benefit for those most at risk for developing stress-induced 
chronic pelvic pain, that is, patients with histories of early life stress. 
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